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ABSTRACT 
 
POTENTIAL ANTI-THROMBOTIC NITRIC OXIDE 







Chair: Mark E. Meyerhoff: 
 
 
 Nitric oxide (NO) is a potent platelet inhibitor released by healthy endothelial cells 
(EC) lining the human vasculature.  Polymeric materials capable of releasing NO from 
synthetic NO donors have exhibited enhanced hemocompatibility in vivo.  Alternatively, 
NO can be catalytically generated from endogenous S-nitrosothiols (RSNO) by some 
organodiselenide species (RSe).  In this dissertation research, a Layer-by-Layer (LbL) 
assembly has been developed to immobilize RSe catalysts on diverse biomedical 
devices/materials to achieve surface NO generation.  Because the preparation of such 
coatings is based on pure electrostatic interaction, universal application of this approach 
is expected.    
 The catalytic LbL was fabricated by manually depositing RSe linked to 
polyethyleneimine (SePEI) with sodium alginate (Alg) on quartz surfaces in an alternate 
 xvi
fashion.  This (SePEI/Alg)n multilayer demonstrated potent catalytic activity to 
decompose RSNO, to NO in presence of free thiols.  Under exaggerated reaction 
conditions, such an LbL exhibited good stability.  The NO generated from given 
concentrations of S-nitrosoglutathione and glutathione is proportional to the number of 
(SePEI/Alg) bilayers deposited.  The LbL was applied to silicone rubber and 
polyurethane substrates to demonstrate its applicability on commercial biomedical grade 
materials.  
 The fabrication of (SePEI/Alg)n LbL was ultimately automated using a commercial 
coating apparatus to achieve higher NO flux by increasing the number of (SePEI/Alg) 
bilayers.  Under typical biological conditions, a (SePEI/Alg)100 was discovered to 
generate an NO flux of 1.5 x 10-10 mol cm-2 min-1 using physiological RSNO levels, 
which is comparable with that of human EC layer.  Even after prolonged contact with 
blood, the multilayer still showed significant NO generation activity.  These 
automatically prepared LbLs were then successfully applied on exemplary metal surfaces 
(nitinol, titanium and stainless steel).   
 In addition, heparin was immobilized on the surface of (SePEI/Alg)n via either 
electrostatic interactions or covalently attaching the anti-coagulant on the aminated LbL 
surface.  Both strategies lead to a surface with combined NO generation and anti-FXa 
activity.  However, the covalent immobilization of heparin resulted in a decreased NO 
generation activity of the underlying catalytic LbL, due to decreased permeability of 
glutathione into the films.        
 xvii
 1
  CHAPTER 1 
INTRODUCTION 
 
 Material induced thrombotic and thromboembolic complications remain a serious 
concern with cardiovascular devices despite the use of anti-platelet (e.g., clopidogrel 
(Plavix®)) and anti-coagulant (e.g., low-molecular-weight heparin (Fragmin®), warfarin 
(Coumadin®), etc.) therapies.  Such thrombogenicity is believed to be inherently 
associated with the foreign character of materials and the only truly non-thrombogenic 
surface hitherto known is the human blood vessel lined with intact endothelial cells (EC).  
Consequently, various approaches have been pursued to decorate material surfaces with 
features mimicking the EC membrane.   
 Nitric oxide (NO), also known as the endothelium-derived relaxing factor (EDRF), 
has been recognized for its critical role in platelet inhibition,1-3 vasodilatation,4 and 
wound healing.5-7 Compounds that can release NO under physiological condition have 
been incorporated within polymeric matrices and a significant reduction in thrombosis 
formation on such NO release surfaces has been observed by both in vitro and in vivo 
assessments.8-11 However, this NO release concept is challenged by limited use-life due 
to the depletion of NO donors in the coatings.  Recently, a novel strategy of catalytically
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generating NO from endogenous NO donors, S-nitrosothiols (RSNO), using 
organoselenium (RSe) species has been pursued to create a long term supply of NO at 
surfaces.12 The work described in this dissertation is closely related to this approach of 
catalytically generating NO from RSNO using RSe catalysts.  Specifically, the 
feasibility of immobilizing RSe catalysts via Layer-by-Layer (LbL) assembly is 
investigated and subsequently proved to be universal on materials with diverse surface 
chemistry, owing to the pure physical driving force involved in the coating process.  
Biomedical polymers and metals were studied in detail to demonstrate that this NO 
generating LbL assembly is readily transferrable to commercial substrates.  Heparin, 
which is a widely used anti-coagulant, was further immobilized on the NO generating 
LbLs for a potential synergic anti-thrombotic efficacy. 
 This introductory chapter will briefly survey current strategies used for improving 
biocompatibility of biomedical surfaces, with specific emphasis on using NO to inhibit 
platelet activity at the blood/device interface and hence to reduce thrombus formation.  
Then, the concept of LbL will be introduced with regard to the processing, the theory 
behind, as well as the uniqueness of this technique.   
 
1.1. Material Induced Thrombosis and Enhancing Hemocompatibility of 
Biomedical Devices 
 Biocompatibility is defined as “the ability of a material to perform with an 
appropriate host response for a specific application”.13 Hemocompatibility, termed 
specifically as the biocompatibility of blood contacting devices, mostly relates to material 
induced thrombosis.  Despite the use of anti-platelet and anti-coagulant therapies, such 
 3
inherent thrombogenicity occurs almost regardless of the physical/chemical properties of 
the material.  Clinical manifestations of the thrombotic response of intravascular devices 
include: sudden and complete obstruction of stents within weeks;14 acute and subacute 
thrombotic occlusion in medium sized vascular grafts;15 embolic complications with 
artificial hearts,16 catheters17 and prosthetic valves;18,19 and thrombotic complications 
during cardiopulmonary bypass15 and angioplasty.20 Even though the risk of thrombotic 
complication appears to be relatively low (varying between 2% and 10% depending on 
the device), the possible fatal outcomes as well as the cost associated with the follow-up 
interventions are not negligible.   
 Many years of intensive research suggests that thrombus forms via a rapid protein 
adsorption of plasma proteins on the device surface followed by two interrelated 
pathways involving platelet and coagulation factors, respectively.  In the platelet 
pathway (see Figure 1.1), platelets deposit on the device surface through binding their 
membrane-bound glycoprotein IIb/IIIa integrin to the surface adsorbed proteins, 
predominantly fibrinogen. The adherent platelets then change in shape to irregular 
spheres with spiny pseudopods, accompanied by internal contraction and extrusion of 
their granule contents into the extracellular environment.  These released agents include 
important mediators (e.g., ADP, fibrinogen, and Ca2+, etc.) that can support platelet 
aggregation and recruit more platelets into the growing platelet aggregate.  When 
platelets aggregate, their membranes provide a phospholipid surface that accelerates two 
critical steps of the blood coagulation sequence (see below).  The platelet clusters are 
eventually interweaved by fibrin fibers into a massive clot, sometimes with red blood 




Figure 1.1. Thrombus formation involving platelets and fibrin on the surface of blood 
contacting biomedical devices.21 
 
 Blood responds to the artificial surface also through a cascade of self-amplifying 
reactions involving at least 12 plasma coagulation factors to form fibrin polymers (from 
fibrinogen) and generate agonists of platelet activation (see Figure 1.2).  The cascade 
can be triggered intrinsically by surface mediated reactions, or extrinsically through 
factors derived from tissues.  The two systems converge upon a final common pathway 
that leads to the formation of thrombin and an insoluble fibrin gel.  At the implantation 
site, the proteins adsorbed on the device react with contact factors and thereby activate 
the intrinsic coagulation system.  In the middle phase of intrinsic clotting, factor IX is 
activated and subsequently forms a complex with factor VIII on the phospholipid surface 
of activated platelets in the presence of calcium.  The common pathway begins when 
factor X is activated by the factor IXa-VIIIa complex.  The active form of factor X 
converts prothrombin (factor II) to thrombin in the presence of factor V, calcium and 
platelet phospholipids.  Thrombin, in addition to its ability to modify factors V, VIII and 
platelet, acts on fibrinogen (factor I) to form polymerized fibrin gel which reinforces  
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platelet aggregates.  
 Contrary to man-made materials, the endothelium layer lining the human vasculature 
remains thrombus-free through several control mechanisms acting in concert: a 
non-fouling phospholipids coating, membrane bound/released inhibitors of platelet and 
coagulation factors, as well as an efficient fibrinolytic system removing fibrin deposits.  
Consequently, surface modifications have been considered to render intravascular devices 
and similar interferential features to mimic the natural thromboresistancy of blood vessels.  
For instance, poly(ethylene glycol)22 and zwitterionic amphiphiles23 such as 
phospholipids24 have been tethered on material surfaces to induce a hydration layer to help 
resist nonspecific protein adsorption.  Surface immobilization of coagulation inhibitors 
have also been explored to prevent blood clotting by deactivating relevant coagulant 
factors.  Examples are surface attachments of heparin25-28 and thrombomodulin28-31 
leading to measurable inhibitory effect on thrombin and factor Xa, and factor Va and VIIIa, 
respectively.  Alternatively, a surface capable of capturing plasminogen, the inactive 
form of the clot degrading enzyme plasmin, has been designed in attempt to decompose 
existing thrombus.32  Although these methods demonstrate positive in vitro results, 
reports on the improvement of in vivo biocompatibility are limited and mixed. 
 
 
1.2. Anti-thrombotic Surface with Nitric Oxide Release or Generation 
1.2.1. Nitric oxide in biological systems 
 The biological importance of nitric oxide had not been appreciated until it was first 
identified as the EDRF in 1987.33  Since then, there has been an explosion of activity 
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revealing this simple small molecule as an active player in critical physiological systems 
such as vascular tone, immunological response, and neurotransmission.34 The major 
source of NO in biological systems is L-arginine which is enzymatically converted by 
nitric oxide synthase (NOS) to L-citrulline accompanied with the liberation of one 
equivalent of NO.  Dependent on the site of formation, NO enters different metabolic 
pathways leading to its degradation or storage.   
 The most studied actions of NO are in the cardiovascular system, where it is 
continuously produced by endothelium nitric oxide synthase (eNOS).  Here, NO can 
diffuse in three dimensions away from the cell of origin, passing through the cell 
membrane easily to bring about a range of physiological effects (see Figure 1.3).  In 
vascular smooth muscle cells (SMC), NO activates soluble guanylate cyclase upon 
binding to its heme component to attenuate cyclic guanosine monophosphate (cGMP) 
levels which results in SMC relaxation.  Nitric oxide also diffuses outward from the EC 
layer into the blood at an estimated rate of 1 x 10-10 mol cm-2 min-1.35  At the 
endothelium-blood interface, NO acts synergistically with prostacyclin to inhibit platelet 
aggregation and disaggregate platelets.  Nitric oxide alone also inhibits platelet adhesion 
to the EC monolayer, further enhancing the thromboresistancy of blood vessels.  
Although the molecular level mechanisms of such anti-aggregation/adhesion activities 
have not yet been fully understood, it is believed that both processes are mediated by a 
cGMP pathway leading to a decrease in the intracellular Ca2+ level which eventually 
deactivates platelets.   
 The fate of NO released into the blood is affected by chemical reactions with blood 




Figure 1.3.  Metabolism of NO in human blood.  NO is synthesized by NOS within the 
endothelium and diffuses into the blood stream to bring about its inhibitory effect on 
platelets, to react with RSH in the presence of O2 to form RSNO, or to be scavenged by 
reactive species, e.g. hemoglobin derivatives. 
 
that bind with NO to form nitrosyl hemoglobin (NOHb), or methemoglobin (metHb) and 
nitrate, respectively.  This rapid scavenging accounts for an extremely short half-life of 
NO in whole blood which results in a highly localized inhibitory effect of NO on platelets.  
Oxidized NO (N2O3) also reacts with free thiols (RSH) which are the most abundant 
reductive species in plasma to form S-nitroso adducts.  Indeed, human plasma contains 
low micromolar concentrations of S-nitrosothiols (RSNO), the majority of which is 
S-nitrosoalbumin (Alb-NO).  These relatively long-lived adducts circulate in the blood 
stream and probably serve as carriers of short-lived NO to regulate vascular tone 
systematically. 
 9
1.2.2. Nitric oxide release from exogenous donors 
 The pharmacological implications of NO become increasingly noteworthy in light of 
its wide-ranging functions in the cardiovascular, nervous and immune systems.  Indeed, 
NO adducts such as organic nitrates36,37 and sodium nitroprusside38 have long been used 
in the treatment of angina and hypertensive crises, respectively.  Therefore, it is not 
surprising that NO has becomes a promising solution for reduction of thrombosis after its 
inhibitory effect on platelets was elucidated.39 Distinct from the other anti-platelet or 
anti-coagulant reagents, NO is truly a local mediator that does not require complex 
metabolism for clearance due to its highly reactive nature.  This has two important 
implications: first, once applied locally, NO can potentially reduce the risk of thrombosis 
without disturbing systemic hemostasis; and second, the exogenous NO source must be 
within close proximity of the implantation site so as to prevent unwanted scavenging of 
NO by a variety of reactive species (e.g., oxyhemoglobin) in the biological environment. 
 Initially, NO was supplied to the site-of-interest using reactive NO adducts capable 
of releasing NO under suitable biological condition (see Figure 1.4). Diazeniumdiolates 
(NONOates), prepared via exposing primary or secondary amines to NO gas, include a 
large array of compounds that have been investigated as potential NO donors for 
biomedical applications.  These compounds undergo spontaneous proton-driven 
decomposition at physiological pH and temperature to generate two molar equivalents of 
NO.  Applying these species on biomedical surfaces can be achieved by simply doping 
discrete NONOate small molecules into polymeric matrices, 11,25,28,40 or covalently 
attaching such species to the polymer backbone.9,41-45 NO release is initiated upon water 
uptake by the polymer and the flux can reach several times that of the EC layer.  In vivo 
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animal studies have demonstrated that biomedical devices such as extracorporeal circuits, 
vascular grafts and implanted oxygen-sensing catheters coated with this NO-releasing 
polymers exhibit dramatically enhanced blood compatibility.11,46,47 However, this NO 
release surface is not good for long term implants because the released NO flux tends to 
decrease due to depletion of the NO donor reservoir.  A decomposition byproduct, 
nitrosoamine, is also of concern for its potential carcinogenicity, if leached out from the 
coating.  An alternative class of NO donors is S-nitrosothiols (RSNO), which have been 
shown to release NO using heat or photo stimuli.  Synthetic RSNOs with a broad range 
of release rates have been achieved by tailoring the parent thiol species.  However, such 
compounds can decompose via more complex catalytic mechanisms via metal ions, thiols, 




Figure 1.4.  (a) Schematic representation of NO releasing materials and (b) exemplary 
compounds of two common NO donors: dibutylhexyldiamine diazeniumdiolate (DBHD, 
top) and S-nitroso-N-acetylpenicillamine (SNAP, bottom). 
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1.2.3. Nitric oxide generation from endougenous S-nitrosothiols 
 As mentioned in 1.2.1, there is a class of compounds with the generic structure 
R-S-N=O known as S-nitrosothiols (RSNO) that exist in animal and human blood.  
These compounds are believed to store and carry transient NO to bring about its systemic 
biological function after being generated by NOS.  The representative endogenous 
RSNOs in plasma include S-nitrosoglutathione (GSNO), S-nitrosocysteine (CysNO) and 
S-nitrosoalbumin (Alb-SNO) (see Figure 1.5).  Although often viewed as an NO adduct, 
RSNO can not be formed by direct reaction between NO and a thiol.  Several possible 
routes have been hypothesized to account for in vivo RSNO formation; however, a 
consensus has not been reached.49 In the laboratory, small molecule (e.g., GSNO and 
CysNO) can be prepared via reacting the corresponding thiol with nitrous acid in 
extremely acidic condition (eq. 1.1a), whereas S-nitroso-proteins can only be approached 
tactfully via a transnitrosation reaction between their cysteinyl residue and small 




 The stability of RSNOs is subject to several factors, such as heat, direct radiation and 
reactive species such as superoxide.48 Particularly, RSNOs can be decomposed by certain 
catalysts to produce NO.  Therefore, the current study of interest focuses on rendering 
the device surface catalytically active to generate NO in situ at the blood/device interface.  
The potential advantage of this NO generation concept is that a sustained NO flux can be 
achieved because the endogenous RSNO levels at the implantation site is constantly 
 12
replenished by blood circulation. 
 It is well established that metal ions, particularly Cu(II), can mediate RSNO 
decomposition.48 In fact，the active species was further recognized as Cu(I) which forms 
from reduction of Cu(II) by a reductive equivalent (i.e., free thiol and ascorbic acid).50  
The Cu(I) then reacts with RSNO to liberate NO by transferring one electron, thus 
forming a disulfide and regenerating Cu(II) (see Figure 1.6).  Such a reaction can be 
partially hindered or completely inhibited in the presence of strong Cu(II) chelating 
reagents (e.g., ethylenediaminetetraacetic acid (EDTA), disulfide, and neocuproine).50,51 
Nevertheless, some Cu(II) complexes still show significant activity to catalyze RSNO 
decomposition (see Figure 1.6), which has lead to design of a series of NO generation 
materials.  For example, a lipophilic Cu complex (e.g., Cu(II)-DTTCT) was blended in 























S-nitrosocysteine (CysNO) S-nitrosoalbumin (Alb-SNO)  
 
 
Figure 1.5.  Structures of common endogenous RSNO species in plasma: GSNO, 





Figure 1.6. Cu(I) mediated RSNO decomposition: mechanism and exemplary Cu(II) 
complex catalysts. 
     
covalently tethered to polymethacrylate54 and high-water-uptake polyurethane.55 Further, 
Cu0 particles in micro/nanometer size were embedded in a polymer phase and this 
material was shown to convert RSNO to NO.56 In this case, the Cu0 particles are corroded 
by the biological fluid (or PBS instead) to release free Cu2+ ion into the peripheral region 
where they are reduced into reactive Cu(I).  These Cu-based NO generation surfaces 
have been reported to be able to generate NO fluxes up to 8 x 10-10 mol cm-2 min-1 from 
biological concentrations of GSNO and GSH.  In an in vivo study, coatings containing 
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Cu0 micro/nano particles were applied on the surface of catheter type oxygen sensors and 
significant thrombosis reduction was observed using a swine model for intravascular 
measurements of oxygen.56 
 In addition to metal ions, RSNO decomposition can also be mediated by 
organoselenium (RSe) species.  This phenomenon was first noted using glutathione 
peroxidase (GPx) to potentiate inhibition of platelets by RSNOs.57 The enzyme has a 
selenocysteine active center which normally converts peroxides into water or alcohols by 
consuming GSH as the reducing equivalent.  The inhibition of platelet was suggested tp 
occur via NO production from the GPx catalyzed RSNO decomposition.  In a later 
mechanistic study, experimental evidence proved that not only GPx, but also some simple 
organoselenium compounds can catalyze RSNO decomposition to NO.58 Recently, the 
reaction was revisited to demonstrate the catalytic mechanism and explore the feasibility 
of producing NO from RSNOs using surface immobilized RSe species.12 Figure 1.7 
shows the proposed mechanism that comprises a fast denitrosation of RSNOs by 
diselenide (eq. 1.3d), and a slower catalytic cycle involving an active selenol species 
(RSeH) (eq. 1.3a-c).  The catalytic intermediate, RSeH, is generated by an interchange 
reaction of diselenide or selenosulfide with the thiol to yield a disulfide.  The RSeH 
subsequently reduces RSNO to form NO and the corresponding selenosulfide forms from 
which RSeH can be regenerated. The NO production rate is dependent on temperature, 
pH, as well as concentration of thiol species, indicating the regeneration of RSeH is the 
rate limiting step.  Indeed, selenol is an efficient catalyst for disulfide reduction to thiols, 
owing to its strong nucleophilicity, good leaving group properties and low pKa value.59  




Figure 1.7. Organodiselenide mediated RSNO decomposition: mechanism and 
exemplary RSe catalysts: 3,3’-diselenodipropionic acid and selenocystamine. 
 
they are in considerable excess.60 In vivo, the abundant GSH reservoir provides the 
necessary reducing equivalents to maintain the redox activity of proteins containing 
selenol active centers, for example, enzymatic degradation of H2O2 by GPx.61 
 Organoselenium based NO generation catalysts are advantageous over Cu based 
species due to the availability of large pool of organoselenium species with reactive 
functionalities, e.g., selenodipropionic acid (SeDPA) and selenocystamine (SeCA).  
These molecules are readily linkable to different surfaces through diverse reaction 
methods.  For instance, SeCA has been covalently immobilized on oxidized cellulose 
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filter paper and ion exchange resin particles.12  Polyethyleneimine was coupled with 
SeDPA via amide bond and the resulting derivative was crosslinked within the pores of 
dialysis membrane.12 Preliminary studies demonstrate these RSe immobilized surfaces 
can catalytically generate NO from RSNO solution effectively in the presence of thiols.12 
1.2.4. Nitric oxide detection with chemiluminescence 
 Despite the availability of diverse NO detection methods, the majority of methods 
described to detect NO rely on probing the relatively stable NO metabolites including 
nitrite, nitrate and metal-nitrosyls.  This can often lead to misleading results, owing to 
the presence of these metabolites in the samples from which NO is to be detected.  
Hence, more complex but direct methods are preferred.  These include 
chemiluminescence, electron paramagnetic resonance (EPR), mass spectrometry, and 
amperometric/voltammetric analysis. Chemiluminescence is of particular advantage due 
to its very low detection limit, selectivity toward NO without separation steps to 
eliminate interferences, good temporal resolution, simple experimental setup as well as 
easy instrumental accessibility.  These features allow direct and continuous monitoring 
of NO flux generated from heterogeneous phases and therefore is utilized as the primary 
tool for NO detection in this thesis work.  
 The chemiluminescence NO analyzer (NOA) detects NO via a reaction with ozone 
(O3) to form a nitrogen dioxide in the excited state (NO2*) which releases a photon as it 
spontaneously relaxes back to the ground state.62 The emission falls in the red and 
infrared region (~640 – 3000 nm) with the peak intensity at ~1100 nm.  Typically, 
commercial instruments are equipped to detect the emitted light in the range between 
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640-900 nm.63 To measure the NO flux, a substrate with catalyst immobilized on its 
surface is immersed in a sealed reaction chamber in which phosphate buffered saline 
containing given concentrations of GSNO and GSH is injected (see Figure 1.8).  A 
given amount of EDTA is also added to chelate any free Cu2+ in the buffer so that only 
the NO generation at the catalytic substrate surface is observed.  The solution is 
constantly purged with N2 to drive NO from the solution phase so as to be carried by the 
N2 stream into the NOA.   
 
 
Figure 1.8. Schematic presentation of experimental set-up for detection of NO generated 
from GSNO/GSH solution using chemiluminescence NO analyzer.  
 
1.3. Surface Modification via Layer-by-Layer Self-Assembly (LbL) 
1.3.1. Layer-by-Layer deposition and the theory behind the technique 
 In 1966, Iler first presented a technique for building films of controlled uniform 
thickness by the alternate adsorption of positively and negatively charged colloidal 
particles.64  Although some singular attempts of similar experiments have been reported, 
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the method was systemically extended to charged amphiphiles and polyelectrolytes by the 
Decher group in 1990s.65 The name “Layer-by-Layer” was given to the method as a 
description of its stepwise coating procedure.  Later, the method has been adopted to 
prepare multilayer assemblies using interactions other than electrostatic ones, such as 
hydrogen bonding, electron transfer, and specific interactions between biological 
molecules.66  It needs to be stressed that the term “LbL” in the context of this thesis is 
limited to the films constructed based on electrostatic attraction of polyelectrolytes.   
 The practical set-up of LbL may be extremely simple, e.g., just dipping the support 
into beakers filled with the polyelectrolyte solutions (see Figure 1.9).  The dipping can 
be done manually, although automatic dipping devices may provide better control and 
enhanced reproducibility.  The amount of adsorbed material is self-limiting and surplus  
 
 
Figure 1.9. Schematic representation of method to construct an LbL. A substrate is 
arbitrarily presumed to bear negative charges on its surface and is immersed in beakers 
containing polycation and polyanion, alternately. The sample is washed when the coating 
solution is switched. To coat a positively charged surface, the substrate is simply placed 
in polyanion solution first, then switch to polycation solution.  
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polymer solution adhering to the support is removed by simple washing with buffer.  
Under proper conditions, a polyelectrolyte with larger than the stoichiometric number of 
charges (relative to the substrate) is adsorbed, so that the sign of the surface charge is 
reversed (i.e., charge overcompensation).  Consequently, when the substrate is exposed 
to a second solution containing a polyion of opposite charge, an additional polyion layer 
is adsorbed.  But this reverses the sign of the surface charge again.  Consecutive cycles 
with alternating adsorption of polycations and polyanions result in the stepwise growth of 
polymer films.  
 The simplest adsorption theory of polyelectrolytes on an oppositely charged surface 
is based on an ion-exchange model: the polyelectrolyte competes with the counterions to 
ion-pair with the charged sites on the surface.  The primary driving force is entropy, not 
enthalpy.  The polyelectrolyte loses entropy upon adsorption, but more entropy is gained 
by the liberated low molar mass counterions.  An additional entropic gain may derive 
from the liberation of solvent molecules from the solvation shell of the polymer-bound 
ionic groups.  In contrast, the number of electrostatic bonds in the overall system is not 
changed upon polyion adsorption.  Inherently associated with its simplicity, this theory 
is far from satisfactory in explaining the diverse behavior of LbL deposition by 
neglecting the role of secondary interactions such as specific ion-ion interaction, 
hydrophobic interaction, electron transfer, hydrogen bonding etc.67 A detailed discussion 
can be found elsewhere.68  
 A factor that dominates LbL deposition is the charge reversal, which is dictated by a 
kinetic controlled process.  The adsorption of polyion is often viewed to proceed in two 
steps: 1) a rapid anchoring of polyions on the surface within minutes; and 2) a slow 
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reconformation of the adsorbed layer via chain rearrangement of the polyelectrolyte.68  
If conformation change is slower than adsorption, charge overcompensation is expected.  
During the fast adsorption, polyelectrolyte chains anchor by only some of their charged 
groups to the surface, and, before they have time to reconform in order to occupy the 
neighboring charged sites on the surface, these latter sites are occupied by other 
polyelectrolyte chains.  The attached polymer molecules progressively create a surplus 
of charge that eventually leads to an electrostatic barrier which repels other 
polyelectrolyte chains from attaching to the substrate.  In other words, the phenomenon 
is self-regulating.  The polyelectrolyte adsorption is not fully reversible so that the 
built-up film does not represent an equilibrium structure.  This adds to the complexity of 
the LbL method by emphasizing careful adjustment of the various coating parameters in 
order to control film growth. 
 LbL gains its remarkable popularity largely because stable films with precisely 
controlled thickness can be prepared using this method without expensive instruments.  
The adsorption cycle comprising consecutive dipping-and-lifting actions has barely any 
limitation on the physical form of the substrates.  Since water is usually used as the 
solvent, this technique is environment friendly.  What most distinguishes the LbL 
method from the conventional surface modification approaches is its generic nature: the 
method can be employed on a wide range of substrates using varied polyions, probably 
due to the pure physical driving force and entropic dominance of the adsorption process.  
Over the past decades, films have been prepared from not only synthetic polymers but 
also proteins,69 dyes,70 inorganic platelets,71 latex particles,72 dendrimers73 and even 
viruses.74  The lack of sensitivity to chemical nature also renders the method useful on 
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almost any substrate materials carrying net charge by choosing proper coating condition.  
Even the sign of the charge is not a problem.  This privilege is superior to traditional 
surface modification methods which require suitable functional groups on both the 
substrates and the immobilized species.         
1.3.2. Properties of Layer-by-Layer assembly  
 In complete contrast to the simplified theory, LbL formation, as well as the properties 
of the resulting films, are highly sensitive to a large number of experimental parameters: 
polyelectrolyte pairs (molar mass, polydispersity, chain stiffness etc.), adsorption time, 
adsorption concentration, ionic strength, pH, low molar mass counterions, solvent, 
rinsing step, and the drying procedure applied between dipping cycles. The influence of 
these parameters has been reviewed elsewhere.75  Combinations of these variables lead 
to countless possible LbL structures presenting diverse composition, physical properties 
and mechanical performance.  An in depth discussion on this topic is out of the scope of 
this thesis and only several common characteristics of LbL will be stressed below. 
 The term “Layer-by-Layer”, although it describes well the coating process, always 
causes misunderstanding with respect to the actual structure of the LbL.  This 
misconception is further enhanced by the alternating surface properties displayed by the 
LbL films, such as contact angle,76 chemical composition77 and ζ-potential, etc.78  
However, a well defined multilayer structure was not detected using X-ray reflectivity79 
or small angle neutron reflectivity.80  This indicates that the LbL is not a hierarchy 
structure with layers of polycation and polyanion superimposed on each other.  Rather, 
the polymers are interpenetrated and the film is stratified.  Since the build-up of such an 
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interdigitated structure does not proceed under thermodynamic equilibrium conditions 
but under control of deposition and wash kinetics, the intuitive stoichiometric 
composition (i.e., polyanion and polycation interacting in a 1:1 ratio) is not obligatory.  
Indeed, both stoichiometic and unstoichiometic films have been reported, although the 
stoichiometric cases seem to dominate.78 Nevertheless, low molar mass ions are found in 
the outmost layers due to the charge overcompensation.81 It is also conceivable that some 
buried charges of the outer layer may not be accessible for polyelectrolyte complexation 
in the next deposition step and hence has to be balanced by small counterions.  
 Once formed, the complexation of weaved polyions is not very reversible.  This can 
be attributed to the high number of ion pairs present, which lock the polyions within the 
LbL film and therefore freeze the multilayer structure.  In many cases, this strong ionic 
bonding also renders the films prepared with outstanding solvent resistance,82 even at 
high ionic strength83 and under strong acidic/basic condition.82 However, such an 
immobilized configuration of polymer in the LbL films does not exclude local chain 
rearrangement.  Actually, a continuous rearrangement of molecular fragments even 
within lower lying layers during film growth is strongly suggested by a number of dye 
labeled systems according to the spectra shifts observed.84,85  An obvious chain 
rearrangement that significantly changes the film appearance has also been observed 
during a so-called annealing event.86  For LbLs made from weak polyelectrolytes, the 
structure may be partially or fully deconstructed upon prolonged exposure in extremely 
high ionic strengths or strongly acidic/basic conditions,87 but the extent is absolutely 
determined by the polyion pair on a case-by-case basis.   
 A distinctive character of LbL is the independency of film growth on the substrate 
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after a certain number of deposition cycles.  This is not surprising considering that the 
charge overcompensation due to the adsorption of the top layer determines the amount of 
adsorbed polyion in the next step.  Observations have been made with many systems 
demonstrating that the thickness of the layers in LbL depends on the chosen 
polycation-polyanion pair.78,88 Accordingly, a linear growth of film thickness and the 
amount of polymer deposited versus the number of dipping cycles is expected for a 
well-behaved polyion pair.  However, nonlinear growth has been often observed in the 
initial stage, i.e. less than 5 bilayers, which is probably attributed to a lack of affinity 
between the polyelectrolyte and the substrate.89  For certain polyion pairs, an 
exponential growth trend or a combination of both regimes can also occur due to the 
diffusion of one polyionic species into the underlying multilayers.90   
1.3.3. Useful substrates for Lay-by-Layer assembly 
 As described above, the build-up of a LbL assembly is initiated by adhesion of 
charged species onto a solid support bearing charge of opposite sign.  Apparently, this is 
easy to realize on materials prone to have net surface charge, e.g., glass, quartz, and 
silicon wafer of which the silanol groups on the surface can be easily deprotonated by 
base.  Some metals, e.g., stainless steel,91 have a naturally occurring surface oxide layer 
that can facilitate anchoring of the polyions without extra surface treatment.   
 However, for practical applications, neutral substrate materials are also desirable, 
mostly organic polymers.  At first glance, these hydrophobic surfaces are thought to be 
not very suitable to apply LbLs.  However, in this circumstance, the surface can be 
primed so as to create a minimal surface charge.  One relatively general method is 
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treating the substrate with an ammonia or oxygen plasma to graft amine or carboxylate 
groups to the substrate.92  Other than chemical modification, pre-adsorption of adherent 
polyions, e.g., polyethylene imine84 or poly(allylamine hydrochloride),93 on the surface 
through nonspecific interactions has also proved to be a viable route to initiate LbL 
deposition.  Besides, specific reactions can be utilized to introduce ionic or ionizable 
functionality.  For instance, commercial poly(ethylene terephthalate), a polyester, was 
briefly treated with hot base to hydrolyze the ester bonds to carboxylate groups.94  All 
these facts illustrate that the natural surface charge is not a strict precondition for 
selecting substrates suitable for the LbL technique. 
1.4. Statement of Dissertation Research 
 The purpose of this dissertation is to investigate the feasibility of immobilizing RSe 
catalysts via an LbL method to develop a NO generating surface based on the catalytic 
decomposition of endogenous RSNOs.  The LbL was characterized for bulk/surface 
physicochemical properties as well as its activity towards NO generation.  Substrates 
with a diverse nature have been selected to apply this novel NO generation coating to 
demonstrate that the LbL technique is truly generic, with application to a broad range of 
surfaces.  The LbL possessing RSe sites can be used as a strategy to endow biomedical 
devices with an EC-like function and hence potentially can improve their 
hemocompatibility.  
 Chapter 2 develops the general concept of building up an RSe immobilized LbL to 
generate NO from RSNOs.  The RSe catalyst was first coupled to a polycation and then 
the resulting conjugate was manually coated on the substrate with a polyanion.  The 
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properties of the resulting LbL were characterized using combined analytical means and 
more importantly, the NO generation behavior of the RSe immobilized in the LbL was 
confirmed.  For characterization convenience, the LbL was primarily applied on quartz; 
however, polymeric substrate surfaces were also examined to prove the genericity of the 
LbL technique.  Aimed at an ultimate biomedical application, the coating was 
preliminarily examined for potential systemic toxicity in concert with local adverse 
effects on the tissue in contact with the RSe contained LbL.  This chapter lays the 
foundation of the entire thesis by demonstrating that the LbL is a feasible route to 
immobilize RSe sites on various solid supports to create NO generating surfaces. 
 Chapter 3 further discusses the benefit of using an automated coating apparatus to 
construct LbLs with up to 100 coating cycles.  This thicker film with more RSe sites is 
shown to be capable of generating an NO flux comparable to that of an EC layer under 
biological conditions. 
 In Chapter 4, three kinds of metals, all of which are widely used to make vascular 
stents, were chosen as representatives of commercial biomedical surfaces to apply the 
automatic coated LbL.  The LbLs were characterized and compared in parallel.  The 
major purpose of this chapter is to show the ease of transferring this NO generation LbL 
from a bench-top idea to real commercial products.   
 Combining the NO generation capacity with a surface immobilized heparin on the 
same LbL coating for a synergic anti-thrombotic potency was explored in Chapter 5.  
Heparin was immobilized through different strategies, i.e. electrostatic adsorption or 
covalent attachment, and the resulting heparinized surfaces were assayed for their 
inhibitory activity on FXa.  The impact of the surface anchored heparin on the LbL 
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stability and RSe site accessibility were also studied.   
 Chapter 6 provides conclusions and future directions for this dissertation work.  
Unresolved technical challenges on this RSe immobilized LbL are discussed.  Potential 
development of novel RSe catalysts as well as LbL with improved performance to suit 
the in vivo animal test is addressed.                    
 Finally, it should be noted that all of the chapters except Chapter 1 and 6 were 
converted from manuscripts published or submitted for publication.  The work described 
in Chapter 2, which is the most significant achievement of this dissertation, has been 
published as a full paper in Langmuir (2008).95  Chapters 3 and 5 will be combined into 
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 NITRIC OXIDE GENERATION FROM S-NITROSOTHIOLS BY 
ORGANOSELENIUM IMMOBILIZED LAYER-BY-LAYER ASSEMBLY 
 
2.1. Introduction 
 As discussed in Chapter 1, NO generation has emerged as a new anti-thrombotic 
strategy by circumventing the depletion of NO donors during long term application.  The 
concept is based on utilizing endogenous S-nitrosothiols (RSNO) as the NO source 
instead of synthetic diazeniumdialote species, and catalytically breaking down RSNOs to 
produce NO at the device surface.  A sustained NO flux is within expectation because 
the endogenous RSNO levels at the implantation site are constantly maintained by blood 
circulation.   
 Organoselenium (RSe) small molecules have been shown to potently catalyze RSNO 
decomposition to produce NO.1 The proposed mechanism comprises a fast denitrosation 
of RSNO by diselenide, and a slower catalytic cycle involving a selenolate intermediate 
which is regenerated by the reducing agent (see Section 1.2.3.).  These RSe catalysts 
have been chemically immobilized on model substrates, and the immobilized RSe sites 
display remarkable catalytic activity.  Although various RSe derivatives are available
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for direct coupling, complicated processing is usually required on the device to provide the 
surface functionality needed for covalent bonding, especially when the devices are made of 
chemically inert materials.  For example, cellulose filter paper was first oxidized by 
periodate to generate dialdehyde groups so that selenocystamine could be subsequently 
immobilized.1  Recently, a carboxylic acid terminated RSe species was covalently linked 
to polyethyleneimine (PEI) which was then crosslinked into a hydrogel film within the 
pore structure of a cellulose dialysis membrane to prepare an amperometric S-nitrosothiol 
sensor.2  Unfortunately, most modern biomedical devices in use do not possess the 
necessary surface functionality, porosity, or geometric form to enable convenient covalent 
attachment of the RSe species.  Hence, a simple and universal immobilization method 
that is applicable to various types of surfaces is needed.  
 As mentioned in Chapter 1, Layer-by-Layer assembly (LbL) is a coating technique 
relying on the electrostatic adsorption of polyions onto a charged substrate and the 
subsequent surface charge reversal.  The distinctive nonspecific driving force allows this 
method to be applied onto substrates with net surface charge regardless of their nature and 
topology.  The properties of an LbL assembly are widely believed to be determined 
primarily by the nature of the polyelectrolytes employed, making this method a truly 
“generic” surface modification approach.  Furthermore, the straightforward dip-wash 
processing in aqueous solution is more economical, environmentally benign and suitable 
for automation.   
 Herein, the feasibility of depositing an LbL film using RSe immobilized 
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polyelectrolyte is investigated (Figure 2.1).  The resulting LbL on quartz substrate was 
characterized using combined analytical techniques.  The catalytic potency of such 
immobilized RSe coatings was studied using GSNO as a model RSNO and GSH as the 
source of reducing equivalent.  Further, the LbL was also applied on polymeric substrates 






Figure 2.1. Nitric oxide generation from endogenous RSNOs by an LbL constructed 




2.2.1.  Materials 
 Polyethyleneimine (PEI, Mw 25 kD), polydiallyldimethylammonium chloride (PDDA, 
Mw 100-200 kD), poly(vinyl sulfate) (potassium salt; PVS, Mw 170 kD), poly(sodium 
4-styrenesulfonate) (PSS, Mw 70 kD), heparin sodium salt (17-19 kD), pentosan 
polysulfate (PPS), poly(acrylic acid) 35 wt.% solution in water (PAA, Mw 100 kD), 
sodium alginate (Alg, Mw 12-80 kD), fluorescein-5-isothiocyanate (FITC), glutathione 
(GSH), 1-(3-dimethylaminopropyl)-3-ethylcarbodiimide (EDC), sodium borohydride 
(NaBH4), N-hydroxysuccinimide (NHS), 2-(N-morpholino)ethanesulfonic acid (MES), and 
2-(N-cyclohexylamino)-ethanesulfonic acid (CHES) were obtained from Sigma-Aldrich 
(St. Louis, MO) and used as received.  The 3140 RTV silicone rubber was purchased 
from Dow Corning Corporation (Midland, MI).  3,3’-Diselenidedipropionic acid (SeDPA) 
and S-nitrosoglutathione (GSNO) were synthesized as described previously.1  All 
solutions were prepared with 18 MΩ cm-1 deionized distilled water obtained from a 
Milli-Q system (Millipore Corp., Billerica, MA). 
2.2.2. Preparation of organoselenium immobilized polyelectrolyte 
 RSe derivatized PEI (SePEI) was synthesized following a procedure slightly modified 
from the one reported earlier.1 Briefly, SeDPA (76 mg, 0.25 mmol) was activated with 
EDC (285 mg, 1.5 mmol) and NHS (115 mg, 1 mmol) and then was allowed to react with 
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given amounts of PEI in MES buffer (pH = 6.0) for 2 h.  The reaction mixture was then 
centrifuged in an Amicon® centrifugal filter unit (MWCO = 3 kD, Millipore Corp., 
Billerica, MA) at 4,000 rpm for 40 min to remove the coupling reagents and any unreacted 
SeDPA.  The resulting yellow SePEI solution was reduced with NaBH4 to break any 
diselenide crosslinks into selenols and then exhaustively dialyzed (Spectra/Por® 7, MWCO 
= 3.5 kD, Spectrum Laboratories Inc., Rancho Dominguez, CA) in 50 mM NaCl for 3 d to 
liberate any unreacted -SeC2H4COOH halves.  The dialyzed solution was concentrated 
into a yellow viscous solution and stored at 4 °C until use.  The Se loading was 
determined by digesting SePEI dry polymer with known mass using fuming nitric acid and 
measuring the Se quantity in the digestion solution using ICP-MS. 
2.2.3. Labeling of SePEI with fluorescein chromophore 
 Despite its characteristic absorbance in near UV region, the diselenides present in the 
LbL coating are not easily observed due to their low quantity and low molar extinction 
coefficient (ε300 = 240 M-1 cm-1).3 Therefore, the SePEI polymer was labeled with FITC 
chromophore (ε495 = 76,000 M-1 cm-1)4 to render the polymer spectroscopically visible. 
SePEI in CHES (2 mg mL-1, 10 mL) was mixed with FITC/DMF solution (1 mg mL-1, 0.8 
mL) under constant stirring for 1 h.  The resulting orange adduct was washed, 
concentrated and redissolved in PBS for subsequent use.  The labeling degree was 
calculated to be 0.53 following protocol provided by Sigma Aldrich.  This labeled SePEI 
was exclusively employed for UV-Vis study to observe stepwise deposition of SePEI 
 38
during the LbL process. 
2.2.4. Fabrication of organoselenium immobilized Layer-by-Layer films on 
quartz  
 All polyelectrolytes were made into 1 mg mL-1 PBS solution (pH = 7.4), except for 
PDDA (Figure 2.2a) which was dissolved in CHES buffer (pH = 9.3).  The quartz slide 
was cleaned using piranha solution (3:7 v/v H2SO4/H2O2 mixture) for 30 min before use to 
fully remove surface impurities.  (Caution: this solution is extremely corrosive.)  The 
LbL multilayer was prepared by manually immersing a quartz slide alternately into the 
polycation (SePEI or PDDA) and polyanion (Figure 2.2b-g) solutions for 10 min.  The 
slide was dip-washed using PBS buffer after each adsorption step to remove any residual 
polymer solution on the surface (see Scheme 2.1).  For UV-Vis characterization, the LbL 
was deposited on the inner wall of a quartz cuvette by filling the cuvette with 
polyelectrolyte solutions or washing buffers in the same sequence as described above.  
Notably, FITC labeled SePEI was used exclusively for UV-Vis characterization, whereas 
plain SePEI was used for all other experiments. 
2.2.5. Characterization of NO generation LbL 
 UV-Vis. The stepwise growth of the LbL film was monitored using a UV-Vis 
spectrophotometer (Lambda 35, Perkin Elmer, MA).  The cuvette was scanned from 550 
nm to 450 nm with a data interval of 1 nm after every (SePEI/Alg) bilayer was deposited. 
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Figure 2.2. Polyelectrolytes used: (a) poly(diallyldimethylammonium chloride) (PDDA); 
(b) sodium alginate (Alg); (c) heparin (Hep); (d) pentosan polysulfate (PPS); (e) 
poly(vinyl sulfate, potassium salt) (PVS); (f) poly(acrylic acid) (PAA); (g) poly(sodium 












Scheme 2.1. Schematic representation of the procedure to manually assemble an LbL 
structure.  The substrate is allowed to adsorb polyelectrolyte molecules for 10 min in 
each polyion solution.  After the adsorption, the substrate is washed in two PBS bathes 




quartz slide or 
polymer tubing 
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 XPS. X-ray photoelectron spectroscopy was performed on a Kratos Axis Ultra XPS 
(Kratos Analytical, England).  The X-ray source employed was a monochromatized Mg 
Kα operated at 10 kV/ 80 W with pass energy of 80 eV.  Charge neutralization was used 
to compensate the charge accumulation on the sample.  The coating was scanned at step 
sizes of 1 eV and 0.1 eV (0.1 s each step) for survey and core scans, respectively.  Prior to 
the measurement, the sample was out-gassed overnight in the sample transfer chamber 
under high vacuum.  The spectrum was processed using CasaXPS version 2.3.12. 
 SEM. Surface morphology of the polyelectrolyte multilayers was examined on a FEI 
Nova Nanolab Scanning Electron Microscope via the detection of secondary electrons.  
The specimens were dried in a N2 atmosphere overnight and then gold coated using a SPI 
Sputter Coater at 18 mA for 60 s for better imaging.  
 Contact Angle. Static air–water contact angles were measured by a sessile drop 
method using a Cam-100 Optical Contact Angle Goniometer (KSV Instruments Ltd., 
Monroe, CT) at ambient humidity and temperature.  The annealed LbL coated quartz 
slides were dried with N2 flow for 2 days.  For each polymer surface, 4 drops were 
examined to obtain the average contact angle values. 
 Quantification of Se in (SePEI/Alg)10. A slide (1 × 2 cm) coated with 10 (SePEI/Alg) 
bilayers was placed in a vial containing 4 mL 100% fuming nitric acid.  The 
polyelectrolyte film immediately peeled off from the slide upon acidification and floated 
freely in the acid.  The vial was capped and kept at room temperature for 24 h during 
which the LbL broke down into a number of small pieces.  Then, the acid was heated to 
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60°C until all these small pieces were completely digested.  The digesting solution was 
brought to a volume of 25 mL using a volumetric flask and sent for ICP-MS to determine 
the Se concentration. Another vial containing same amount of nitric acid but without the 
multilayer digest was also prepared following the same protocol and was used as a control. 
 Se Leaching Test. (SePEI/Alg)10 was coated on glass shell vials (1.5 cm ID, 3.5 cm, 
Fisherbrand®, Fisher Scientific Inc., Pittsburgh, PA) with a coating area calculated to be 
12.4 cm2.  Four mL of PBS buffer containing 100 µM GSH and 50 µM GSNO was added 
to each vial, which was enough to submerge the entire coating area, to extract leachable 
selenium species from the LbL.  The vials were then capped, wrapped with aluminum foil, 
and kept at room temperature for 5 d.  Every 24 h, the extracting solutions were collected 
and the vials were refilled with fresh PBS buffer containing the same concentrations of 
GSH and GSNO.  After 5 d extraction, the coatings were digested using nitric acid to 
quantify the remaining Se in the LbL.  The extracts and digesting solutions were brought 
up to a volume of 25 mL for eventual ICP-MS measurements. 
 In Vivo Toxicity Study. Samples for in vivo toxicity study were prepared following 
ISO standards 10993-11 and ISO 10993-12.  LbLs containing 10 bilayers were coated on 
the inner surfaces of glass shell vials (1.7 cm ID, 6.5 cm, Fisherbrand®, Fisher Scientific 
Inc., Pittsburgh, PA) with a surface area calculated to be 28.9 cm2.  The vials were filled 
with 12 mL phosphate buffered saline or vegetable oil to reach a surface-volume-ratio of 
2.4 cm2 mL-1.  The vials were capped and incubated at 37 ˚C with constant agitation for 
72 h.  Systemic toxicity and irritation tests were performed following ISO 10993-11 and 
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ISO 10993-10, respectively. 
 NO Detection. Substrates coated with (SePEI/Alg)n LbL films were inserted into a 
PBS test solution (2 mL, pH = 7.4) containing GSNO and GSH.  The NO produced was 
purged from the solution with N2 flow and detected using a chemiluminescence NO 
analyzer (NOA) (Sievers 280, Boulder, CO).  The amount of NO evolved from the 
solution was calculated based on the calibration curves of the NOA, which were obtained 
regularly by plotting the integrated NOA signal (ppb·s) during calibration vs. the 
introduced amount (moles) of NO into the system via nitrite reduction in an acidified 
potassium iodide solution.  To prevent unwanted RSNO decomposition from external 
thermal or photo stimuli,5 all NOA tests were performed at room temperature using amber 
reaction vessels.  Lights in the laboratory were also turned off when these experiments 
were conducted.  EDTA was added to the testing solution in order to eliminate any GSNO 
decomposition catalyzed by trace metal ions, e.g., Cu(II). 
 In Vitro Blood Test. Fresh heparinized (5 U mL-1) sheep whole blood was obtained 
from ECMO Laboratory in the Medical School at the University of Michigan.  Three mL 
of blood was carefully transferred into a 15 mL polypropylene centrifuge tube.  A glass 
slide coated with (SePEI/Alg)10 was gently positioned in the blood.  The tube was sealed 
and wrapped with aluminum foil to avoid light exposure. During the entire procedure, the 
blood surface was kept below the top of the coating to prevent any accidental contact with 
bare glass.  After 24 h incubation at 4 °C in the dark, the slide was removed and rinsed 
with PBS buffer to wash off any loosely adsorbed blood residue.  A control slide was 
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immersed in 3 mL PBS and processed following the same procedure.  The ability of the 
LbL to generate NO from GSNO was then examined by the chemiluminescence method 
described above. 
 Preparation of Polymeric Substrates. Silicone tubing (0.64 mm ID/1.19 mm OD, 2 
cm), purchased from Helix Medical Inc. (Carpinteria, CA), and 5 Fr double lumen 
polyurethane catheter (Cook, Denmark) were cut into 1-inch segments.  The open ends of 
these segments were sealed with RTV 3140 SR followed by curing under ambient 
conditions overnight.  Before immersion in polyelectrolyte solutions for LbL deposition, 
the polymeric substrates were cleaned by sonicating in deionized H2O and ethanol for 20 
min each.  The silicone rubber surfaces were soaked in PBS overnight before priming 
treatments, whereas the polyurethane substrates were directly coated with (SePEI/Alg)n 
without a precursor layer. 
 
2.3. Results and Discussion 
2.3.1. Synthesis of RSe derivatized polyelectrolyte (SePEI) 
 To integrate catalytic activity into an LbL structure, a small molecule organoselenium 
species, e.g., 3,3’-diselenodipropionic acid (SeDPA), must be covalently linked to a 
polycation or polyanion without significantly compromising the capability of the 
polyelectrolyte to interact with its oppositely charged counterpart.  Polyethyleneimine was 
selected due to its abundant primary amine sites within the structure which can be reacted 
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readily with an activated carboxylic acid group.  An EDC/NHS mediated coupling 
reaction was adapted from a previously reported procedure (Scheme 2.2).1 After separation 
from the reaction mixture, the modified PEI shows a light yellow color acquired from the 
diselenide bond indicating a successful immobilization of SeDPA onto the polymer. 
 Although SeDPA has two carboxylate groups capable of reacting with PEI, sometimes 
only one of the two carboxylic acids forms the desired amide bond, leaving an unreacted 
half molecule attached to the polymer through a diselenide bond with the reacted half.  
When the diselenide bond is reduced by GSNO or GSH during the NO generation reaction, 
the unreacted half molecule may leach out and could ultimately cause serious toxicity 
concerns.  Consequently, the SePEI was reduced with NaBH4 after the coupling reaction 
to break all the diselenide bonds into selenols, as indicated by the disappearance of the 
distinctive yellow color from the diselenide species.  The reduced SePEI was then 
exhaustively dialyzed to remove any SeDPA halves detached from the polymer.  After 
dialysis, the polymer concentrate regains its yellow color indicating that the selenols are 
oxidized back to diselenides during the dialysis. 
 As summarized in Table 2.1, the loading of RSe sites on PEI can be adjusted by 
controlling the reaction stoichiometry between SeDPA and PEI.  SePEI3, SePEI7 and 
SePEI12, termed with respective to the weight percentage of elemental Se, were obtained.  
Also, the ratio of reacted –NH2 and –COOH in the final product was back calculated 








Scheme 2.2.  Scheme of SePEI preparation by an EDC/NHS coupling reaction between 
SeDPA and PEI.  Unreacted SeDPA halves are liberated by dissecting the diselenide 
bond with NaBH4 and removed through exhaustive dialysis.  The reduced RSeH is 








Actually, it is necessary to keep some of the primary amines ionizable so that the modified 












SePEI3 2.3 0.25 1 : 0.065 2.8±0.2 % 
SePEI7 1.2 0.25 1 : 0.16 6.6±0.1 % 
SePEI12 0.6 0.25 1 : 0.3 11.5 % 
 
Table 2.1. Summary of SeDPA/PEI coupling stoichiometry and the composition of 
corresponding products.  The moles of primary amine sites in PEI reactant are calculated 
based on a 1:2:1 ratio of primary, secondary and tertiary amines. 
 
 
 The attachment of SeDPA onto PEI inevitably impacts the properties of the polycation.  
Indeed, SePEI12 formed an insoluble precipitate after dialysis.  This may be attributed to 
the greater consumption of ionizable amine sites which significantly contributes to the 
good solubility of PEI in water.  Furthermore, the coupling of SePEI introduces more 
hydrophobic alkyl components to the PEI and therefore lowers its hydrophilicity.  SePEI7, 
due to its higher RSe content and high solubility, was used throughout the entire 
dissertation work to construct NO generation LbL films and is generally termed as 
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“SePEI” for simplicity. 
2.3.2. Preparation of LbL from SePEI and different polyanions (PA) 
 In order to deposit an LbL film, the positively charged polymer, i.e., SePEI in this 
context, has to interact with a polymeric species bearing negative charges.  Several 
synthetic and natural anionic polymers (Figure 2.2b-g) were therefore allowed to pair with 
SePEI.  The criterion used to select the best candidate was the amount of SePEI deposited 
on the quartz cuvette within a given number of coating cycles.  In this study, FITC 
labeled SePEI (SePEI-FITC) was used to render the coating spectroscopically visible.  
The labeled SePEI shows a maximum absorbance at 500 nm due to the FITC chromophore.  
Hence, the absorbance from the resulting LbL was measured at the same wavelength.  
The quartz cuvette was first filled with a weakly basic CHES buffer (pH = 9.3) containing 
PDDA, a strong polyelectrolyte species bearing permanent ammonium ions, to enhance 
the ionization of the surface hydroxyl groups on the quartz.  Then, the polyanions were 
allowed to interact with the PDDA layer and the coating cycle was repeated one more time 
to form a (PDDA/PA)2 priming layer before SePEI was used to replace PDDA (see Figure 
2.2a) to continue the LbL deposition.  For each polyelectrolyte pair, UV-Vis measurement 
was taken after 4 and 8 (SePEI/PA) bilayers were coated.  The absorbance change within 
these 4 bilayers was used to compare the interaction between SePEI and different PA 
species.  
 As shown in Figure 2.3, an increase of UV absorbance was observed for all the PAs  
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Figure 2.3. UV-Vis absorbance change at 500 nm for different SePEI/PA pairs between 
the 4th and the 8th coating cycles.   
 
except heparin, indicating formation of polyelectrolyte LbLs.  However, the ΔAbs varied 
markedly dependent on the polyanionic species: PSS only weakly interacted with SePEI 
giving a ΔAbs just above zero; PPS, PAA and PVS gave medium UV increases (0.01 ~ 
0.02); Alg demonstrated the strongest capability of associating with SePEI, as indicated by 
a ΔAbs as high as 0.12.  In general, the polysaccharide polyanions adsorb more SePEI 
than their polyvinyl counterparts carrying the same anionic functionality, i.e., Alg and PPS 
gave higher ΔAbs than PAA and PVS, respectively.  So far, there is still a lack of sound 
theories that can be strictly followed to interpret these disparate complexation behaviors 
across different polyelectrolyte pairs.  This is because the interaction between two 
oppositely charged species is highly susceptible to a number of factors such as molecular 
weight, ionic groups, chain stiffness and charge density, etc.6 As a consequence, it is very 
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difficult to conduct systematic structure-interaction studies by varying only one parameter 
while keeping the others the same.  However, it is reasonable to postulate that the relative 
rigid polysaccharide chain, compared with the polyvinyl backbone comprising freely 
rotating C-C single bonds, may prevent the polysaccharides from effectively matching 
their negative charges with the ammonium groups on SePEI.  This ineffective interaction 
may result in more unbalanced charges which reciprocally adsorb more polyions in the 
next deposition step, despite the binding between the polyion pair being somewhat weaker.  
Notably, Hep showed a negative ΔAbs, implying that some of the SePEI molecules were 
desorbed from the quartz surface upon interacting with the Hep chains in the polyanionic 
solution.  This is probably caused by the formation of a soluble polycation-polyanion 
complex.  Based on these results, Alg was finally chosen to construct the NO generation 
LbL in attempts to maximize the amount of RSe catalyst immobilized in the film for a 
given number of coating cycles. 
2.3.3.  Stepwise growth of (SePEI/Alg)n LbL on quartz 
 The successive adsorption of (SEPI/Alg)n on quartz cuvette can be discerned by 
visually examining the quartz substrates after every immersion in Alg solution.  After the 
4th cycle, the quartz slide became cloudy and continuously lost its transparency as more 
bilayers were deposited.  The presence and propagation of this cloudiness suggest 
formation of a heterogeneous film structure which is attributed to the fast adsorption 
kinetics.7 When the substrate is alternately immersed into SePEI and Alg solutions, the 
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polyions associate at the interface at such a fast rate that many defects are trapped and 
chain rearrangement does not have sufficient capacity to “heal” the defects in time before 
another coating cycle.  In good agreement with these visual observations, UV-Vis spectra 
of the LbL films exhibit a steady background absorbance increase owing to the 
heterogeneity of the multilayer.  Upon baseline subtraction, the UV-Vis spectra display 
consecutive increments after each coating cycle with a maximum absorbance at 503 nm 
(see Figure 2.4).     
 The absorbance at 503 nm was then extracted to plot against the number of bilayers in 
the LbL (see Figure 2.5).  Interestingly, the UV-Vis data exhibits an “S” shape rather than 
a uniformly linear or exponential type curve that is typically observed in LbL assembly.8-10 
The slope of the curve is very flat initially but becomes steeper from the 4th bilayer and 
then flattens again from the 6th bilayer.  Such a variation suggests a possible surface 
morphology evolution of the LbL, given that the SePEI is electrostatically attracted by the 
existing multilayer on the substrate.  Therefore, SEM snapshots of (SePEI/Alg)n were 
taken to assess surface features at various stages of the coating process.  The initial 
(PDDA/Alg)2 precursor layer is found to provide a smooth and even coverage on the 
quartz substrate (Figure 2.6a).  One (SePEI/Alg) bilayer only slightly roughens the 
surface with scattered islands that are hardly distinguishable from the background owing to 
their small dimensions (Figure 2.6b).  When more layers of the polyelectrolytes are 








































Figure 2.6. SEM of (SePEI/Alg)n on quartz slide: (a) (PDDA/Alg)2 precursor layer; (b) 
(SePEI/Alg)1; (d) (SePEI/Alg)2; (d) (SePEI/Alg)3; (e) (SePEI/Alg)4; (f) (SePEI/Alg)5. 
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diameter of ca. 2 µm, which considerably roughen the surface (Figure 2.6c-d).  This 
observation supports the same heterogeneous LbL structure implied by the UV-Vis study.  
In fact, a recent study has reported that LbL coatings do not start growing as a successive 
superposition of interacting polymer layers, and polyelectrolyte adsorption is kinetically 
stopped by the surface potential reversal other than at full coverage of the substrate.  In 
this case, the PEI crosslinked by the diselenides possesses a bulkier conformation 
compared with linear polyelectrolytes, which further sterically impedes the effective 
interaction of the SePEI with the substrate.  As a result, little adsorption of SePEI can 
accumulate enough positive charge to reverse the surface potential, which explains the 
slow increase in UV-Vis adsorption for the first couple of coating steps.  A full coverage 
of the surface is finally realized after 4 bilayers (Figure 2.6e); however, the earlier coarse 
structure can still be vaguely recognized from the bumpy surface contour.  Continuous 
deposition of polyelectrolytes significantly smoothes the bumpiness and leads to more 
modest surface irregularities (Figure 2.6f).  The transition from discrete particles to 
continuous layer as well as the subsequent smoother surface can be attributed to the 
propensity of polyelectrolytes to bridge over the underlying defects.  Based on the SEM 
data, we speculate that the over-adsorption of SePEI from the 4th to 6th bilayer is chiefly a 
matter of greater surface roughness which increases the surface area.  After the 6th bilayer, 
the growth enters a “self-regulated” regime where the structure and properties of the LbL 
converge into a state determined by the nature of the polyelectrolyte pair. 
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2.3.4. Enhanced early stage growth of (SePEI/Alg)n on quartz substrates by 
(PDDA/Alg)2 precursor layer 
 Quartz is usually treated as naturally negatively charged due to its silanol surface 
groups which deprotonate effectively under basic conditions.  However, the ionization of 
a weak base such as PEI is hindered by high pH.  Therefore, adsorption of a layer of 
PDDA at a pH ≈ 9 can enhance the ionization of silanol groups while stabilizing the 
surface charge by forming ion pair with quarternized ammonium on PDDA.  Indeed, the 
priming (PDDA/Alg)2 layer does promote the adsorption of the following (PEI-FITC/Alg) 
LbL.  As shown in Figure 2.7a, the quartz slide pre-adsorbed with (PDDA/Alg)2 shows a 
higher absorbance from FITC-SePEI than slide without priming treatment.  Notably, this 
enhancement only occurs in the early stage (up to 5 bilayers) of the LbL growth. When 
more bilayers are coated, the difference between SePEI-FITC absorbed on the primed and 
unprimed slides remains the same.  This trend can be viewed more clearly in Figure 2.7b.  
This is not surprising by considering that the original (PDDA/Alg)2 primed surface, 
although it attracts more SePEI in the first couple of cycles, is eventually fully covered by 
(SePEI/Alg) bilayers.  From then on, the LbL enters a substrate-independent regime so 
that the adsorption of polyelectrolyte is dominated by the existing LbL. 
2.3.5. Annealing of (SePEI/Alg)n LbL 
 The kinetically limited layer-by-layer adsorption results in a heterogeneous film 































Figure 2.7. (a) UV-Vis absorbance at 503 nm for (SePEI-FITC/Alg)n coated on unprimed 
(solid square) and (PDDA/Alg)2 primed (solid triangle) quartz slides; (b) Absorbance 
difference between (SePEI-FITC/Alg)n on unprimed and primed quartz slides for a given 




















required to reduce the existing defects through self-rearrangement of polymer chains. 
Although the chain mobility in an LbL film is almost completely lost in the dry state, it can 
be regained to a certain degree upon rewetting.7 We find that a (SePEI/Alg)5 annealed in 
PBS containing 100 µM GSH can revert to a film with greater clarity (see Figure 2.8).  
The annealed LbL retains 92.2% of its original FITC absorbance suggesting that the 
observed improvement in film clarity is not due to delamination of the multilayer.  
 In contrast, the specimen annealed in PBS without the presence of GSH only partially 
loses its cloudiness.  The presence of GSH likely facilitates the healing process by 
reducing most of the diselenide crosslinks and hence renders SePEI chains more flexible to 
rearrange into a more thermodynamically stable conformation.  The SEM images taken at 
low magnification clearly show that the fuzzy appearance of freshly coated LbL surface 
develops into a denser layer embedded with coarse clumps up to 10 µm in diameter after 
annealing (see Figure 2.9).  Such a surface conformational change further verifies the 
occurrence of chain rearrangement. 
2.3.6. Characterization of annealed (SePEI/Alg)n 
 The stability of (SePEI/Alg)n LbL is critical for a long lasting catalytic activity. 
Delamination of the multilayer will gradually reduce the surface NO generation and 
therefore weaken the anti-thrombotic efficiency.  Also, the delaminated organoselenium 
species will provoke potential toxic side effects.  To assess the stability of the NO 




Figure 2.8. Appearance of a freshly coated (SePEI/Alg)5 (left), (SePEI/Alg)5 annealed in 
PBS buffer without addition of GSH for 12 hours (middle), and (SePEI/Alg)5 annealed in 




Figure 2.9. SEM of a (SePEI/Alg)5 coated on quartz slide before (left) and after (right) 




presence of exaggerated amounts of GSH and GSNO.  The PBS/GSH/GSNO mixture 
was refreshed on a daily basis to maximum the reaction time.  After a 4-day exposure in 
PBS containing 100 μM GSH and 50 μM GSNO, the multilayer preserves 95.3% of its 
original UV-Vis absorbance from the FITC tracer within the film (see Figure 2.10).  
Compared with the previously annealing experiment in which the LbL lost 7.8% UV-Vis 
absorbance within a period of 12 h, the annealed LbL indeed shows an improved stability.   
 The annealed (SePEI/Alg)n LbLs were also characterized via contact angle.  Figure 
2.11 shows the static contact angles of the films at each deposition step with pure water 
measured in atmospheric air at room temperature.  In the early stage, the LbL exhibits 
similar contact angles regardless of which polyionic species is the outermost layer.  This 
can be explained by the prevalent occupancy of the surface by the initial (PDDA/Alg)2 
precursor layer due to the poor coverage of the (SePEI/Alg)n.  From the 3rd coating cycle 
onward, the contact angles fluctuate periodically between 64.1 ± 3.3° for the SePEI as the 
outermost layer and 56.7 ± 3.1° for Alg as the outermost layer.  The relatively lower 
contact angle of Alg outlayer is primarily due to the large amount of hydroxyl groups on 
the polysaccharide.  This back-and-forth change of surface tension further verifies the 
LbL buildup of the film by alternate deposition of SePEI and Alg. 
 The chemical composition of the (SePEI/Alg)n LbL was studied using X-ray 
photoelectron spectroscopy (see Figure 2.12).  The peak at 57 eV was identified as Se 3d 
electron, which confirms the successful immobilization of RSe species within the 















Figure 2.10. Stability studies on a (SePEI/Alg)5 coated on the inner wall of a quartz 
cuvette. The cuvette was filled with PBS containing 50 μM GSNO and 100 μM GSH. 
After every 24 hours, old soaking solution was decanted and the cuvette was refilled with 
fresh PBS containing same given concentrations of GSNO and GSH. The absorbance at 
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Figure 2.11. Contact angles measured from films of a different number of adsorbed layers 
of polyelectrolytes. Integral numbers represent films with Alg as the outmost layer; 








Figure 2.12. X-ray photoelectron spectroscopy of a (SePEI/Alg)15 coated on quartz 







H2PO4- and Cl- small ions in the buffer in which the LbL was deposited.  The 
stoichiometry between SePEI and Alg was derived based on the atomic percentage of N 
and O assuming that all the N and O were contributed by the polyamine and 
polysaccharide, respectively.  Interestingly, the amine:carboxylate ratio was calculated to 
be 3.89.  This indicates that the deposition of SePEI and Alg does not follow a 
stoichiometric (i.e., a 1:1 ratio) pattern.  Similar to low molar mass weak acid and base, 
the polymeric counterparts may undergo a partial ionization dependent on the local 
environment.  In this circumstance, the uncharged repeat units do not participate in 
forming an ion pair with the oppositely charged component and hence the stoichiometry 
between two constituent polyelectrolytes will deviate from an ideal 1:1 ratio. 
 The partial ionization of SePEI is also reflected by the split of its N1s envelope 
observed in the core scan.  As shown in Figure 2.13, the N1s electron is composed of two 
peaks, one centers at 399 eV while the other at 402 eV.  The peak at higher binding 
energy is empirically assigned to cationic N atom due to the stronger binding of electron 
by the local positive charge.  To better estimate the ratio of cationic and neutral amines, 
the N1s envelope was curve fitted into 6 components: cationic primary amine, neutral 
primary amine, cationic secondary amine, neutral secondary amine, tertiary amine, and 
amide.  Integration of each component reveals that only 27.5% of the SePEI amines are in 
their ionized form.  Such a low ionization degree is expected for branched PEI in which 
secondary and tertiary amines distribute densely along the polymer backbone.  







Figure 2.13. Curve fitting of N1s envelope in XPS core scan.  The spectrum was 
smoothed twice using Savitzky-Golay approach with a smooth width of 5.  Six 
components were simulated including the amides resulting from the coupling of SeDPA to 









the amines within close proximity.  Indeed, the pKa values of different amine sites within 
branched PEI were reported to be 9.2, 8.2, 5.8 and 4.3, respectively.11 Most of the cationic 
amines are likely contributed by the uncoupled primary amines locating at the end of the 
branches of PEI molecules, which are far away from each other and thus invoke less 
repulsive interaction upon protonation.  If this partial ionization of SePEI is taken into 
account, the ratio of cationic amines and carboxylates is close to a 1:1 ratio.  This 
explains the appearance of only a trace amount of small counterions in the film, although 
the total amine is in great excess to the carboxyl groups of the Alg species.  
2.3.7. Preliminary toxicity evaluation of (SePEI/Alg)n  
 For all materials targeting an ultimate biomedical application, special attention must 
be paid with the regard to their biological safety.  Specifically for this NO generating LbL, 
the organoselenium species which is required for catalytic activity may also cause  
potential side effects if leached into the biological system.  Although selenium is widely 
known as an essential trace element in the diet, deficiency of the element is associated with 
many health conditions such as immune dysfunction, cardiovascular disease, depression, 
and oxidative stress.12 However, the toxicity of selenium has also been well recognized 
and correlated to the oxidation state of selenium.13 The upper limit of selenium intake for 
humans from all sources is 400-450 µg per day as recommended by several expert 
panels.12 An overdose beyond this limit may be seriously toxic, and fatalities have been 
reported, albeit very rarely.13,14  
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 Accordingly, the (SePEI/Alg)n LbL was assessed for its toxic risk caused by any 
leachable selenium species from the film.  The leaching test was performed on a 
(SePEI/Alg)10 by extracting the film under exaggerated reaction conditions for 5 d.  Then, 
the extracted LbL was completely digested using fuming nitric acid to quantify the 
remaining selenium in the film.  The abundance of selenium element within the 
(SePEI/Alg)10 was determined to be ca. 2.9 μg cm-2 (0.036 µmole cm-2) (see Table 2.2).  
After the 5 d extraction, only 3.0% of the Se leached out from the multilayer intro the 
extracting solution.  It is noteworthy that the average daily dietary intake of selenium in 
the United States is consistently above 55 μg/d and a super-nutritional level (> 100 μg/d) is 
suggested to optimize its anti-oxidation potency.  If applied on medical devices with 
limited surface area, e.g., on a vascular stent, the LbL contains several micrograms of 
selenium in total which would be equal to only a small fraction of normal dietary intake. 
The exact Se species that leaches from the LbL films has not been identified; however, it is 
possibly that this leaching is attributed to the instability of aliphatic organoselenium 
species.  Diselenides are known to undergo alkaline hydrolysis in basic conditions.15 
Therefore, it is possible that SeDPA is slowly destabilized by the basic local environment 
created by the amine sites on PEI.  Also, the anionic selenolate intermediate is a very 
good nucleophile and a strong reductive species.  This species can undergo a series of 






CL: Se concentration in extracting solution. 
CT: Se concentration in digesting solution. 
%: percent Se leached out from the LbL during the 5 d extraction period. 
C: Se content per unit area in (SePEI/Alg)10. 
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Table 2.2. Selenium quantification and leaching test of (SePEI/Alg)10 as measured by 
ICP-MS. (SePEI/Alg)10 was coated on glass shell vials (1.5 cm ID, 3.5 cm). The coating 
area was calculated to be 12.4 cm2. The coating area was submerged in 4 mL PBS buffer 
containing 100 μM GSH and 50 μM GSNO to extract leachable selenium species from the 
LbL. The vials were then capped, wrapped with aluminum foil and kept at room 
temperature for 5 d. The extracting solutions were collected very 24 h and the vials were 
refilled with fresh PBS buffer containing same given concentrations of GSH and GSNO. 
After the 5 d extraction period, the LbLs were digested using 100% fuming nitric acid. 
Both extracting and digestion solutions were then brought into 25 mL solutions using 





 In vivo toxicity tests were also conducted using animal models.  Phosphate saline and 
vegetable oil were selected to extract the LbLs taking into account that the leachable 
compounds may have various affinities with different extracting vehicles.  The aqueous 
and oil phase extracts were administrated to two groups of five mice via intravenous and 
intra-peritoneal injection, respectively.  Within an observation window of 28 d, neither 
group of mice tested develops any systemic toxic symptoms such as weight loss (see 
Figure 2.14), prostration or any neurological signs.  The oil phase extract was also given 
to a rabbit model intradermally to test the local tissue response.  Within 72 h, the dosed 
areas did not display any clinical sign of irritation such as rash, inflammation and swelling, 
etc. excluding presence of any irritants in the extraction solution (see Figure 2.15).  All 
these toxicity evaluations, albeit still at a preliminary stage, show that this (SePEI/Alg)n is 
very promising for biomedical applications. 
2.3.8. Nitric oxide generation by (SePEI/Alg)n from S-nitrosoglutathione 
 The catalytic activity of (SePEI/Alg)n deposited on quartz slides was investigated by 
measuring NO generation from GSNO with GSH as reducing agent via 
chemiluminescence.  Figure 2.16b shows a typical chemiluminescence result obtained 
from a (SePEI/Alg)5.  Nitric oxide production is initiated instantly upon introducing the 
slide into the test solution and rapidly plateaus at a sustained NO level.  When the slide is 
removed, the NO generation ceases almost entirely, indicating the catalytic GSNO 











































Figure 2.14. Measured weights of the mice injected with saline (top) and oil phase 








Figure 2.15. Pictures of the three test spots where the oil phase extracts were injected 






removal of the slide replicate the up-and-down NO generation pattern.  The NO flux 
degrades slightly over time which is likely attributed to the consumption of the GSNO in 
the bulk test solution.  Although GSNO can directly react with GSH to produce nitroxyl 
and potentially compete with the catalytic GSNO decomposition employed in our 
experiments,16 we believe that the reaction rate for nitroxyl formation is much slower and 
the RSe catalyst dependent GSNO decomposition is the primary reaction by which GSNO 
is consumed in the reaction mixture.  The marginal baseline increase after slide removal 
suggests only a very small amount of catalyst leaches from the LbL film into the test 
solution during the measurements, with no severe delamination of the catalytic multilayer 
observed.  Indeed, the return to baseline in the chemiluminescence experiments after 
removing the LbL coated substrate is a very sensitive means to probe the degree of 
leaching, since any loss of RSe species will induce a homogenous reaction which is much 
faster than the heterogeneous surface reaction mediated by the LbL.  An assembly that 
had not been annealed was also tested (see Figure 2.16a).  When the slide was removed, 
approximately 60% of the NO flux remained without the presence of the substrate in the 
NO generating solution, implying that some catalytically active species had been released 
into the test solution from the coating.  Such results further confirm the enhanced stability 
of the LbL assembly that is induced by the annealing step. 
 It should be also recognized that a solid polymer matrix would likely block the free 
diffusion of the reactive GSNO and GSH species from penetrating into such a coating.  If 









Figure 2.16. NOA studies of (a) fresh prepared (un-annealed) and (b) annealed 





the amount of NO generation would be solely dictated by reactions at the outer surface of 
the polyelectrolyte coating but not the number of bilayers within the LbL film.  However, 
if the film is truly permeable to GSNO and GSH, there should be an increase in observed 
NO production for thicker films.  Hence, (SePEI/Alg)n with various numbers of catalytic 
bilayers were tested to evaluate the accessibility of the RSe sites within the LbL.  Figure 
2.17a clearly shows the maximum NO flux increases from 56 ppb for (SePEI/Alg)5 to 106 
and 146 ppb for (SePEI/Alg)10 and (SePEI/Alg)15, respectively.  Meanwhile, the 
background solution phase NO generation (after slide removal) does not show a significant 
increase for the greater number of bilayers deposited.  This proves that the enhanced NO 
production is indeed derived from the access to the RSe catalyst in the underlying layers of 
the LbL coating.  The correlation between the maximum NO flux observed in NOA 
studies and UV-Vis adsorption of LbL with various numbers of bilayers is nearly 
proportional (see Figure 2.17b).  Such a result implies a very open film structure in which 
most of the immobilized RSe species are able to contribute to GSNO breakdown even for 
films with 15 bilayers.  This is an attractive feature of this new NO generating coating in 
that the degree of NO generation from given RSNO/RSH concentrations can be controlled 
by the number of bilayers deposited. 
 In a longer term study, ten separate aliquots of PBS buffer (2 mL in each aliquot) 
containing the same initial concentrations of GSNO and GSH (50 μM and 100 μM, 
respectively) were allowed to react successively with a single quartz slide coated with a 
(SePEI/Alg)10 (see Figure 2.18).  The LbL was kept in each test solution until the NO 
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Figure 2.17. (a) NO generation by (SePEI/Alg)n on quartz with various number of 
bilayers in PBS containing 50 μM GSNO, 50 μM GSH and 0.1 mM EDTA. The slide 
was immersed (↓)/removed (↑) as indicated by the arrows. (b) NO flux vs. UV-Vis 
absorbance of (SePEI/Alg)n at 503 nm. 
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production fully stopped and subsequently transferred to the next test solution.  After 
continuously reacting for 40 h in total, the LbL still exhibited significant catalytic activity. 
The conversion rate of GSNO was calculated separately for all 10 reactions, revealing that 
the GSNO in each batch was completely depleted.  The estimated Se content in the LbL 
was 0.11 μmol, while the total GSNO decomposed was 1 μmol.  It is obvious that the 
(SePEI/Alg)n can decompose more GSNO than the amount of Se immobilized in the 
multilayer film, further proving that the reaction is catalytic in nature.  The extended 
reaction time also resulted in a slower kinetics. Compared with the 1st batch, the maximum 
NO flux in the 10th experiment decreases about 60%, while the time required to 
decompose all the GSNO is almost doubled. 
 The organoselenium immobilized LbL was also tested in vitro to preliminarily 
evaluate its activity after prolonged contact with sheep whole blood (see Figure 2.19). 
Without spiking additional GSNO, the endogenous GSNO and other RSNO species in the 
blood decrease rapidly due to the consumption by the catalyst.  After a 24 h contact, the 
LbL was thus partially covered by thrombus (since NO generation ceases without more 
substrate).  When the blood clots were carefully peeled off using tweezers, the LbL 
underneath still displayed significant catalytic activity in generating NO from a fresh 
GSNO/GSH solution and was able to fully convert all the GSNO added in the reaction. 
However, the LbL in contact with blood displayed a lower NO generating activity (ca. 
50% less) compared with the control which had been in contact only with PBS buffer.  























Figure 2.18. Long term NO generation by a slide coated with (SePEI/Alg)10. Ten batches 
of PBS (2 mL each) containing 50 μM GSNO and 100 μM GSH were allowed to react 




























Figure 2.19. NOA of (SePEI/Alg)10 after 24 h incubation in (a) PBS; (b) sheep whole 
blood. Please note that both measurements were stopped before the added GSNO was 
depleted. The NOA curves here represent the average NO generation rate rather than total 






the multilayer is delaminated simultaneously upon the clot removal and herein reduces the 
catalyst quantity in the assembly.  Further, protein adsorption on the LbL surface may 
also impede diffusion of GSNO/GSH reactants into the coating and this results in slower 
reaction kinetics.  Nevertheless, the in vitro blood contact study strongly suggests that 
(SePEI/Alg)n LbL coatings can preserve significant activity after exposure to blood 
components for an extended time period. 
2.3.9. Application of (SePEI/Alg)n LbL on polymeric surfaces. 
 The primary motivation for this study is the potential application of this RSe 
immobilized LbL approach to render biomedical materials/devices more biocompatible via 
spontaneous generation of NO from endogenous NO precursors.  Toward this goal, it is 
important to demonstrate that the (SePEI/Alg)n film can be coated on biomedical grade 
silicone rubber and polyurethane, both are widely used to make biomedical devices. 
Several methods were examined to create surface charge on silicone rubber, including 
silanization with 3-aminopropylsilane (APS), adsorption of PDDA, and adsorption of 
SePEI.  The treated silicone surfaces were characterized by contact angle measurement. 
As shown in Figure 2.20, the contact angles of treated surfaces range between 114.8° and 
116.8°, which are 4-6° lower than the control silicone rubber that was immersed in PBS for 
the same period of time.  Such decreased surface energy proves that all these three 
priming methods induce a certain degree of hydrophilicity to the surface, presumably due 






























Figure 2.20. Contact angle measurements on silicone rubber surface adsorbed with 
different polymer.  Glass slides were dip-coated with RTV Silicone Rubber (20% in THF) 
and cured in ambient condition overnight before utilized as flat silicone substrates.  The 
silicone substrates were then immersed in solutions containing 3-aminopropylsilane 
(APS), PDDA, and SePEI for 2 hours.  Another slide was immersed in PBS for the same 
amount of time and used as blank.  The contact angles were measured using the same 









contact angle after treatments are larger than 90°, implying the overall surface nature is 
still very hydrophobic.  This indicates that the amount of priming species adsorbed on the 
surface is very limited.  The surface charge of the treated silicone tubing was reversed by 
a layer of Alg and further stabilized with (PDDA/Alg)2 before (SePEI/Alg)n LbL film was 
assembled.  UV-Vis revealed the same “S” shape growth pattern and little disparity in 
respective of the amount of SePEI deposited in the resulting LbLs, regardless of the 
various surface charging methods employed (see Figure 2.21).  The LbL assembly was 
also applied on the surface of PU catheters without precoating with (PDDA/Alg)2 
precursor layer.  Indeed, PEI can adsorb on polymeric surfaces via hydrophobic 
interaction to introduce cationic amine groups and initialize LbL growth.17  
 Figure 2.22 shows the NO generation from (SePEI/Alg)10 coated on (a) silicone 
tubing and (b) PU catheter upon repeated immersion and removal of the LbL coated tubing 
into a PBS solution with 50 μM GSNO and 50 μM GSH.  The coated devices with 10 
bilayers exhibit similar up-and-down NO generation pattern, indicating that the LbL 
fabricated on polymeric surface without dense surface charge still possesses reasonable 
stability.  In concert with the experiments performed on quartz slides, these results prove 
that the (SePEI/Alg)n behaves similarly even when applied on substrates with vastly 
different initial surface properties.  The normalized NO fluxes observed when in contact 
with a 50 μM GSNO and 50 μM GSH solution are 2.4 × 10-10 and 1.8 × 10-10 mol min-1 
cm-2 for silicone and PU substrates, respectively.  These are comparable with the 




















Figure 2.21. UV-Vis study of (SePEI/Alg)n buildup on silicone rubber treated with 
different charged polymers: silanization with APS, adsorption of PDDA, and adsorption 
of SePEI. The FITC labeled SePEI species was employed in this study.  UV-Vis spectra 









Figure 2.22. Nitric oxide generation from PBS containing 50 μΜ GSNO, 50 μΜ GSH 
and 0.1 mM EDTA by (a) (SePEI/Alg)10 on silicone rubber tubing; (b) (SePEI/Alg)10 on 
PU catheter without application of (PDDA/Alg)2 precursor layer. The segment of 
polyurethane catheter or silicone rubber tubing was immersed (↓)/removed (↑) as 





































































endothelium cell lining the blood vessels.  While the NO levels that would be generated 
when devices are in contact with fresh flowing blood will vary depending on the levels of 
RSNOs and free thiols (i.e., GSH and cysteine), recent studies have shown that NO 
generating polymer coatings based on copper catalysts, that carry out the same reactions as 
the RSe used here, do reduce thrombus formation on catheter surfaces when implanted in 
pig arteries for up to 20 h (compared to controls in the same animals).19 
 
2.4.   Conclusions 
 In summary, a novel strategy to immobilize catalytic organoselenium species via a 
shown capable of forming an LbL structure with Alg as the counter-polyelectrolyte.  An 
annealing treatment is required to further stabilize the multilayer.  The LbL shows overall 
neutrality with PEI and Alg interacting with their ionized amine and carboxylate sites in a 
nearly 1:1 ratio.  The RSe catalysts immobilized within the LbL were capable of 
generating NO from GSNO, an endogenous NO precursor, for an extended time period. 
The surface confined polyelectrolyte matrix exhibits sufficient permeability to GSNO and 
GSH small molecules to access catalytic sites deep within the structure.  Even after 
prolonged contact with blood, the LbL still preserves significant catalytic activity.  Our 
preliminary studies using silicone rubber and polyurethane substrates clearly demonstrate 
that this NO generating surface can be easily adapted onto currently commercialized 
biomedical polymers used for vascular grafts, catheters, etc.  It is noteworthy that the 
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mechanical LbL coating process could be very time consuming if more bilayers are 
demanded, albeit the coating mechanism is rather simple.  Usually a manually coated 
LbL contains only up to 20 bilayers, which already takes ca. 10 h to complete. 
Layer-by-Layer deposition method has been described.  The RSe immobilized PEI was 
Therefore, research described in Chapter 3 of this thesis will focus on the benefit of using 
an automated coating apparatus to prepare thicker LbL films with more bilayers to 
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 FABRICATION OF NITRIC OXIDE GENERATION LAYER-BY-LAYER 
ASSEMBLY USING AUTOMATED APPARATUS  
  
3.1. Introduction 
 In Chapter 2, an LbL possessing immobilized RSe sites that showed substantial NO 
generation activity from RSNOs was demonstrated.  A carboxylate derivatized RSe 
catalyst, SeDPA, was coupled onto PEI and the modified polycation was manually 
assembled into a thin film containing 5 to 20 (SePEI/Alg) bilayers.  Quantification using 
ICP-MS revealed that the amount of RSe species immobilized within a (SePEI/Alg)10 is 
only about 0.036 μmole cm-2.1 Therefore, high concentrations of GSNO and GSH (e.g., 
50 μM each) were used in the experiments reported to enhance the NO generation so that 
the NO generation trend can be better observed.  Nevertheless, it would be more 
meaningful to present the catalytic activity of such LbLs using physiologically relevant 
levels of GSNO and GSH.  The GSH level in plasma is reported to be about 20 μM,2 
while the concentration of GSNO is suggested to be within a micromolar range.3 A 
manually coated (SePEI/Alg)10 was tested accordingly using 2.5 μM GSNO and 20 μM 

































Figure 3.1. Nitric oxide generation by (SePEI/Alg)10 from 2.5 μM GSNO and 20 μM GSH 
at 37˚C. A piece of glass slide coated with the LbL was immersed into the test solution 
and then removed as indicated by the (↓) and (↑) arrows.  
 
NO flux is still lower than the 0.5-4 x 10-10 mol cm-2 min-1 basal NO flux from healthy 
endothelial cells.4  To promote greater NO generation, more catalytic sites need to be 
incorporated in the LbL.  In other words, more bilayers have to be assembled.  
Although the LbL technique is widely appreciated for its simple processing, the 
fabrication can be very time-consuming and it is therefore not suitable for manual 
preparation if a large number of bilayers are needed.  For example, deposition of an LbL 
consisting of 50 bilayers takes almost 24 h of nonstop work, assuming that the substrate 
is immersed in each polyelectrolyte solution for 10 min.  Therefore, automation of the 
coating process will be beneficial to free manual labor as well as to provide more 
consistency.     
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 In this chapter, we report our achievements in preparing LbLs using an automatic 
coating apparatus to assemble as many as 100 bilayers.  With physiological 
concentrations of GSNO and GSH, these LbLs generate NO fluxes comparable to that of 
natural human endothelial cells.  Even with a hundred bilayers, the LbL structure shows 
excellent stability under exaggerated reaction conditions.  The surface morphology of 
the LbLs was also examined using electron microscopy. 
       
3.2. Experimental 
3.2.1. Materials 
 Polyethyleneimine (PEI, Mw 25 kD), sodium alginate (Alg, Mw 12-80 kD), and 
glutathione (GSH) were purchased from Sigma-Aldrich (St. Louis, MO) and used as 
received.  Organoselenium immobilized PEI (SePEI) and S-nitrosoglutathione (GSNO) 
were synthesized as described previously.1 All solutions were prepared with 18 MΩ cm-1 
deionized distilled water obtained from a Milli-Q system (Millipore Corp., Billerica, 
MA).  Five Fr Cook® double lumen polyurethane catheters were obtained from Accord 
Biomaterials Inc. (Ann Arbor, MI). 
3.2.2. Preparation of (SePEI/Alg)n Layer-by-Layer assembly 
 The quartz slide was cleaned using piranha solution (3:7 v/v H2SO4/H2O2 mixture) 
for 30 min before use to fully remove surface impurities.  (Caution: this solution is 
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extremely corrosive.)  The LbL multilayer was prepared by immersing a quartz slide 
alternately into SePEI and Alg solutions (1 mg mL-1) for 10 min each.  In order to 
assemble more bilayers in a single LbL assembly, an automatic coating instrument 
StratoSequence 6 (Nanostrata Inc., Tallahassee, FL) was employed.  The automatic 
fabrication protocol differs from the manual method primarily in its extended washing 
step, in which the substrate is sequentially immersed in three batches of PBS for 1 min 
each after adsorption of one layer of polyelectrolyte (see Scheme 3.1). 
3.2.3. Characterization of NO generation LbLs 
 NO Detection.  Nitric oxide generation from (SePEI/Alg)n LbLs coated on metal 
substrates was quantitated as described in Chapter 2. 
 SEM.  Surface morphology of the polyelectrolyte multilayers was examined on a 
FEI Nova Nanolab Scanning Electron Microscope via the detection of secondary 
electrons.  The specimens were dried in a N2 atmosphere overnight and then gold coated 
using a SPI Sputter Coater at 18 mA for 60 s for better imaging. 
 Se Leaching Test and Quantification of Total Se in the LbL.  A piece of 
(SePEI/Alg)100 with a known surface area was placed in a vial filled with 10 mL of PBS 
buffer containing 100 μM GSH,  50 μM GSNO and 0.1 mM EDTA to extract any 
leachable selenium species.  The vial was then capped, wrapped with aluminum foil, 













was refilled with fresh PBS buffer containing the same concentrations of GSH, GSNO 
and EDTA.  After 3 d extraction period, the extracts were combined and brought to 50 
mL using a volumetric flask.  The extracted coating was then digested using 10 mL 
fuming nitric acid and brought to a final volume of 100 mL.  The extract and digesting 
solution were then sent for ICP-MS measurements to determine the Se concentrations. 
 In Vivo Implantation.  To evaluate the in vivo performance of the (SePEI/Alg)100, 
the LbLs were deposited on 5Fr Cook® polyurethane catheters without any priming 
treatment.  The cannular tip of the catheter was automatically sealed during the coatings 
by the LbL.  Before implantation, a catheter was cut down to 1 cm long segments and 
tested for its NO generation activity.  Another intact catheter was then implanted in the 
jugular vein of a New Zealand rabbit for 4 h.  The catheter was then explanted, cut into 
1 cm long segments, and assessed for its post-surgery catalytic activity.  
      
3.3. Results and Discussion 
 Layer-by-Layer assemblies, in spite of their simple and straightforward fabrication, 
are highly sensitive to the coating parameters in terms of their structure and physical 
properties.  This is because the surface charge reversal is a consequence of the 
kinetically controlled adsorption of the polyelectrolyte, rather than a thermodynamically 
dictated process.  Therefore, transition from a manual fabrication to an automatic 
protocol may also alter the NO generation behavior of the resulting LbL.  Although it 
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takes 6 minutes longer to complete one bilayer in the automatic method, the extensive 
washing indeed turns out to be beneficial in producing more stable LbLs.  As discussed 
in Chapter 2, the manually coated LbL has to be annealed in a GSH solution for hours to 
obtain a stable structure that shows a clear up-and-down NO generation pattern.  This is 
because the LbL is formed by a kinetically controlled process.  If the freshly prepared 
multilayer structure is not given enough time to cure, it is unstable and tends to 
reorganize if the coating remains wet.5 For the NO generation LbL, such reorganization 
is always associated with leaching of the RSe species, which potentially can cause 
serious toxicity issues.  However, the automatically coated LbL shows excellent 
stability even without the annealing process (see Figure 3.2).  Assemblies containing 40 
and 100 bilayers were tested immediately after deposition to give NO generations of 140 
and 420 ppb, respectively.  The NO productions quickly diminished to less than 10 ppb 
when the coatings were removed from the GSNO and GSH reservoir, indicating that the 
NO was predominantly produced within the LbL.  These observations prove that the 
LbLs are very stable and the annealing treatment is not necessary for LbLs prepared with 
the automated dip method.  This is most likely attributed to the prolonged washing 
during which the polyelectrolyte chains were allowed to reorganize into a more stable 
conformation.  Notably, the (SePEI/Alg)40 and (SePEI/Alg)100 multilayers display 
similar residual NO productions, which clearly demonstrates that the stability of the LbL 



















Figure 3.2. Nitric oxide generation from 50 μM GSNO and 50 μM GSH by 
(SePEI/Alg)40 and (SePEI/Alg)100. The (↓) and (↑) arrows indicate that the LbL was 
immersed into or removed from the test solution. The coating areas are estimated to be 
about 3.3 cm2.   
 
 The NO generation was also plotted against the number of bilayers in the LbL (see 
Figure 3.3).  When more bilayers were assembled into the LbL, the catalytic activity of 
the coating increased correspondingly, reflected by an almost linear trend of the NO flux 
produced from the same concentrations of GSNO and GSH.  This observation is in 
accordance with the data obtained from manually coated LbLs (see Figure 2.17 in 
Chapter 2).  Such a result implies a very open film structure in which most of the  





















Figure 3.3.  Correlation between number of bilayers (n) and NO generation from 50 
μM and 50 μM GSH.  
 
immobilized RSe species are able to contribute to GSNO breakdown.  This is an 
attractive feature expected from the LbL technique; i.e., that the degree of NO generation 
from given RSNO/RSH concentrations can be controlled by the number of bilayers 
deposited. 
 The primary goal of using an automatic apparatus and preparing an LbL with many 
bilayers is to immobilize more catalytic sites so that enough NO can be generated from 
the typical concentrations of GSNO and GSH present in the biological environment.  
Hence, a (SePEI/Alg)100 was evaluated for NO generation capability using 2.5 μM 
GSNO and 20 μM GSH at room temperature.  According to chemiluminescence, the 
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multilayer generated NO at a flux of 1.6 x 10-10 mol cm-2 min-1 (see Figure 3.4).  This 
value is within the range of 0.5 and 4 x 10-10 mol cm-2 min-1, which is the estimated NO 
flux generated by healthy endothelium cells.4 The sample was then preserved in PBS 
buffer at 4°C with its activity followed up periodically using the same experimental 
configuration.  The activity shows a sluggish decrease over time; however, the coating 
retained at least 85% of its original activity after 17 d (see Figure 3.5).  This result, in 
conjunction with the production of a biological level of NO, suggests that such an LbL 





































Figure 3.4. Nitric oxide generation by (SePEI/Alg)100 from 2.5 μM GSNO and 20 μM 
GSH at room temperature. The (↓) and (↑) arrows indicate that the LbL was immersed 























Figure 3.5. Long term activity of (SePEI/Alg)100, tested using 2.5 μM GSNO, 20 μM 
GSH and 0.1 mM EDTA at room temperature.  
 
 Although the (SePEI/Alg)n LbL shows good catalytic activity and stability in vitro, 
exposure to blood rich in reactive biological species may have an adverse impact on the 
catalysts.  Therefore, the (SePEI/Alg)100 was constructed on a PU catheter which was 
then implanted in a rabbit vein.  The NO generation activities were evaluated before and 
after the implantation (see Figure 3.6).  Before implantation, the LbL gave a peak NO 
flux of 1.5 x 10-10 mol cm-2 min-1 from 1 μM GSNO and 20 μΜ GSH.  After 4 h, the 
catheter was explanted and found to be covered by blood clots.  The reason for such a 
failure of this NO generation coating in terms of thromboresistancy might be very 







Figure 3.6.  Nitric oxide generation by (SePEI/Alg)100 coated on a PU catheter before 
(top) and after (bottom) implantation in a rabbit vein for 4 hours. The NO generation was 




















































































After removal of the clot, the catheter was gently washed and tested for NO generation.  
Under the same conditions, an NO flux of 1.2 x 10-10 mol cm-2 min-1 was produced by 
this explanted LbL, which was very close to the flux before implantation.  This result 
highlights a very encouraging fact that LbL does survive the sheer stress of the flowing 
blood and its catalytic efficiency is preserved even in direct contact with the blood 
components. 
 The surface morphology of coatings comprising 50 and 100 bilayers was imaged by 
SEM.  Notably, the drying process is a critical parameter dictating the surface texture.   
When coarse evacuation or air-blowing was applied, the LbLs often exhibited rough 
surfaces with bumps and holes.  In contrast, smoother surfaces were observed on 
samples capped in vials to let water evaporate naturally.  As shown in Figure 3.7, 
(SePEI/Alg)50 exhibits a very smooth and featureless appearance under the microscope; 
however, (SePEI/Alg)100 shows a surface texture resembling an orange peel.  We 
speculate this unevenness is related to the diselenide crosslinks within the SePEI, 
because the LbL constructed using PEI without diselenide coupling displayed a very 
smooth surface (data not shown).  Another possibility is that the polyions in the LbL 
form a scattered microcrystalline region upon drying,6 although the polyelectrolyte 
complexes commonly show amorphous structures owing to their fast binding.  
 The potential toxicity concern of these automatic coated LbL was also assessed by 





Figure 3.7. SEM snapshot of (SePEI/Alg)50 (left) and (SePEI/Alg)100 (right).    
 
conditions.  A piece of (SePEI/Alg)100 with a surface area of 3.8 cm2 was extracted with 
PBS containing 50 μM GSNO, 50 μM GSH and 0.1 mM EDTA.  Approximately 3.1% 
Se was found released into the extracts after three days.  Such a leach rate is very 
similar to the Se leaching observed in manually coated LbL, indicating that the increase 
of coating cycles does not compromise the cohesion between the oppositely charged 
polyelectrolytes in the LbL.  This discovery implies an “unlimited” multilayer growth in 
terms of the structural stability of the resulting LbL.  The total abundance of Se element 
in the LbL was also determined to be ca. 93.9 μg cm-2.  It is not surprising that this 
concentration is much higher than the 2.9 μg cm-2 Se that was found in the manually 
coated (SePEI/Alg)10; however, one may also notice that this 30 fold increase is not 
proportional to the increase of the number of bilayers.  This is because the manual and 
1 mm 
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automatic coating protocols should be viewed as two distinctive systems due to the 
sensitivity of the LbL to the exact deposition process. 
3.4. Conclusion 
 In this chapter, LbLs with up to 100 bilayers were realized using an automatic 
coating apparatus.  As expected, a physiologically relevant level of NO can be 
generated from low concentrations of GSNO and GSH if enough catalytic sites (i.e., the 
number of bilayers) were deposited on the substrate.  We also successfully 
demonstrated that the catalytic activity was sustainable over an extended period of time, 
which indicates these NO generation LbLs are suitable for long term cardiovascular 
implants. 
 Despite of all these positive aspects regarding this automated preparation of NO 
generating LbLs, there are still many unresolved issues.  Most importantly, whether the 
NO flux generated by these LbLs is enough for thrombosis prevention still needs further 
proof.  Recently, the lowest NO flux required to maintain an extracorporeal circulation 
loop free of thrombosis was suggested to be about 13 x 10-10 mol cm-2 min-1.7 Intuitively, 
one can see that this flux threshold is device-dependent, i.e., a larger device tends to need 
a higher surface NO supply to be thromboresistant.  It should also be noted that the 
hemocompatibility of the EC layer involves synergic efforts of several anti-platelet and 
anti-coagulant species.  If present alone, the NO flux probably needs to reach a higher 
dose to completely suppress the coagulation response.  The ultimate answer for this 
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question lies in evaluating these (SePEI/Alg)n LbLs in vivo using suitable substrates and 
animal models.  Clearly, this generic NO generation LbL, as described in Chapter 2, 
allows for the selection of a substrate of any nature and dimension to fit the needs for a 
given in vivo implantation. 
 In our preliminary in vivo implantation, the LbL coated catheters were found covered 
by blood clots after explantation.  It is still premature to draw any conclusions about the 
efficacy of this NO generation surface.  First of all, the RSNO level in the blood is 
highly dependent on each individual animal, and is a critical variable dictating the NO 
generation rate.   Presence of other prothrombotic surface features such as a rough 
surface contour and selective protein binding may further offset the NO potency.  It will 
be necessary to conduct more detailed investigations to better understand the surface 
biochemistry of the (SePEI/Alg)n multilayer and hence to fine tune its surface 
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 Percutaneous transluminal coronary angioplasty (PTCA) has become the major 
intervention for coronary atherosclerosis to remove the lipid/cholesterol deposits and 
restore the blood flow through the diseased arteries.  During PTCA, a stent mounted on an 
angioplasty balloon is delivered to the target site and deployed via balloon inflation to open 
the vessel with the atherosclerotic plaque.  The balloon is then withdrawn, while the stent 
is left behind as a scaffold to preserve the luminal patency of the newly widened vessel.  
 Clinical outcomes point to the beneficial impact from stent placement in preventing 
vessel recoil/re-closure.1 However, the recipients are under risk of several stent-related 
complications, including sub-acute thrombosis which occurs in 1 to 3% of patients within 7 
to 10 days of the procedure.2 This complication has been largely mitigated by aggressive 
multidrug treatments with anti-platelet agents (e.g., clopidogrel, aspirin, and glycoprotein 
IIb/IIIa inhibitors, etc.) and anti-coagulants (e.g., heparin, and warfarin).  However, 
well-documented side effects, such as gastrointestinal toxicity and internal bleeding, have 
also been associated with these antithrombotic treatments.3,4 Nitric oxide, owing to its 
propensity to react with many biological species, has potential advantages over other
 104
pharmacologic treatments in its highly localized effect and multi-pathway metabolism.5 
Therefore, it is of interest to demonstrate the applicability of the previously described NO 
generation LbL (see Chapter 3) to the stent relevant metallic surfaces.   
 In this chapter, three exemplary biomedical metallic materials (see Table 4.1) were 
selected to study the feasibility of fabricating (SePEI/Alg)n LbLs on their surfaces.  
Stainless steel 316L (SS) is the classic material to make stent struts owing to its well-suited 
mechanical properties.  The low carbon content of this material tremendously reduces the 
possibility of in vivo corrosion, making this alloy very useful for long term implantation.  
Nitinol (NiTi), a shape memory alloy, is used to fabricate self-expanding stents which have 
a smaller diameter at room temperature and expand to their preset diameter at body 
temperature.6 Titanium (Ti) is also studied in particular in this work, although pure Ti is not 
commonly used as the sole stent material.  Due to its low ductility, Ti stents are more 
prone to fracture; however, such an inadequate mechanical property does not limit the 
metal from coronary stent applications.  Indeed, coatings comprising titanium oxide and 
nitride have proved to be more biologically inert with reduced platelet and fibrinogen 
deposition.7-9 Recently, Ti-based tantalum and niobium alloys have shown excellent 
hemocompatibility and hence are potentially useful as stent materials.10 Similar to Chapter 
3, a homemade automatic coating robot was employed to fabricate the catalytic NO 
generation thin films on these metal surfaces.  The consecutive build-up of the multilayer 
was monitored by the mass of the polyelectrolytes deposited on the metal, as well as the Se 
content in the coating.  The resulting metal based (SePEI/Alg)n were examined for their 




     




 Polyethyleneimine (PEI, Mw 25 kD), sodium alginate (Alg, Mw 12-80 kD), glutathione 
(GSH), and lysozyme from chicken egg white were purchased from Sigma-Aldrich (St. 
Louis, MO) and used as received.  Bovine albumin fraction V solution was purchased 
from Invitrogen Corp. (Carlsbad, CA).  Reagent grade acetone and ethanol were acquired 
from Fisher Scientific (Pittsburgh, PA).  Sheets of stainless steel 316L, medical grade 
titanium, and nitinol were acquired from Accord Biomaterials Inc. (Ann Arbor, MI).  
S-Nitrosoglutathione (GSNO) and organoselenium immobilized polyethyleneimine 
(SePEI) were synthesized as previously described.11  Phosphate-buffered saline (PBS, 10 
mM, pH = 7.4) was prepared in the laboratory.  All the solutions were prepared with 18 
MΩ cm-1 deionized-distilled water via a Milli-Q filtration system (Millipore Corp., 
Billerica, MA).  
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4.2.2. Preparation of nitric oxide generation Layer-by-Layer on metal 
substrates  
 Metals were cut into 1 x 3 cm strips and sequentially sonicated in acetone, ethanol, and 
deionized water (10 min each) shortly before the LbL assembly process.  A homemade 
automated LbL deposition system (see Chapter 3) was employed to ensure consistency of 
the deposition cycles across various samples.  The LbL was coated by alternately dipping 
the metals in 1 mg mL-1 SePEI and Alg solutions (10 min each) with three intermediate 
PBS washings (1 min each) to remove loosely attached species prior to deposition of the 
next counter polyion layer.  Such a coating cycle was repeated until the desired number of 
bilayers was reached.  Upon completion of the LbL process, samples were dried in 
ambient air.  
4.2.3. Characterization 
 NO Detection.  Nitric oxide generation from (SePEI/Alg)n LbLs coated on metal 
substrates was quantitated as described in Chapter 2. 
 SEM.  Surface morphology of the polyelectrolyte multilayers was examined on a FEI 
Nova Nanolab Scanning Electron Microscope via the detection of secondary electrons.  
The specimens were dried in a N2 atmosphere overnight and then gold coated using a SPI 
Sputter Coater at 18 mA for 60 s for better imaging.  
 Quantification of Total and Leachable RSe Species in the LbL.  Metals with a 
known surface area (usually 1or 2 cm2) were coated with (SePEI/Alg)n and then extracted 
in 1 mL PBS buffer (pH = 7.4) containing 50 μM GSH, 50 μM GSNO, and 50 μM EDTA at 
37 °C for any leachable organoselenium species.  The extract solution was refreshed on a 
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daily basis to maximize reaction time.  At the end of the 3 d extraction, the extracts were 
combined, brought to 25 mL using deionized distilled water and sent for ICP-MS analysis 
to determine selenium concentration in the solution.  Metal strips from the previous 
selenium leaching study were separately submerged in fuming HNO3 (Caution: fuming 
HNO3 is extremely corrosive.), which resulted in a gradual delamination and digestion of 
the LbL film.  A total of 5 mL of fuming HNO3 was used and the bare metals were 
removed when the digestion was complete (~ 2 d at room temperature).  The digestion 
solution was then brought to 250 mL with DI water and sent for ICP-MS analysis.   
 
4.3. Results and Discussion 
 Different from the quartz substrates employed in Chapters 2 and 3, metals are 
completely opaque objects. This distinctiveness excludes spectroscopic characterization of 
the LbL structure by measuring the transmitted light.  As a result, the build-up of the 
multilayer was confirmed via measuring the mass of the polyelectrolytes deposited on the 
metal surface.  As shown in Figure 4.1, four pieces of SS and Ti were weighed separately 
and subsequently coated with 25, 50, 75 and 100 bilayers of (SePEI/Alg), respectively.  
Due to the limited quantity of substrate, only two pieces of NiTi were coated with 50 and 
100 bilayers, respectively.  The samples were then completely dried and their masses were 
acquired again.  The mass of the LbL was then derived by subtracting the initial mass of 
the metal substrate from the mass after the LbL deposition, followed by normalization 
against the coating area.  On all three metals, the mass of the LbL correlated positively 
with the number of bilayers.  Remarkably, fitting the data into a linear trend yielded a 
similar slope across all three substrates, meaning the growth of the multilayer (i.e., the 
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amount of polyions deposited in a single bilayer) was not substrate specific within the 
range of 25 to 100 bilayers.     
 The successful construction of the multilayer structure was also proved by detecting 
the Se content within the LbL using ICP-MS.  As shown in Figure 4.2, the elemental Se 
content within the multilayer also displayed a linear correlation with the number of 
bilayers.  Meanwhile, it is not surprising that the Se concentrations in the LbLs are also 
substrate nonspecific, except for (SePEI/Alg)100 coated on NiTi which slightly deviated 
from the Ti and SS data.  One may notice that there are contradictory data obtained on 
NiTi, which seemed to absorb a lower amount of polyelectrolytes but contain more Se.  It 
must be noted that the masses that were manipulated in aforementioned experiment were 
very small (only several milligrams), which makes the results shown in Figure 4.1 more 
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Figure 4.1. Mass of (SePEI/Alg)n coated on metal substrates (1 x 3 cm). 
       SS   y = 0.031x + 0.033 
Ti    y = 0.0309x + 0.1083 



















Figure 4.2. Se density within (SePEI/Alg)n coated on SS, Ti, and NiTi. 
 
 The catalytic activity of the LbL coated on metal substrates was first evaluated using 
excess GSNO and GSH to better elucidate the trend.  It revealed that the LbLs coated on 
different metal substrates possessed similar NO generation capability (see Figure 4.3).  
With 50 μM GSNO and 50 μM GSH, the LbLs yielded a considerable NO production upon 
immersion in the reaction solution.  When the catalytic multilayer was removed from the 
reaction reservoir, the NO generation almost completely ceased.  The slight baseline 
increase indicated predominant heterogeneous NO production within the multilayer 
structure.  The structural stability was also revealed by the leaching studies in which the 
leachable RSe species were extracted from (SePEI/Alg)50 using exaggerated reaction 
conditions with 50 μM GSNO and 50 μM GSH.  After 3 d extraction period, the LbLs 
















Figure 4.3. NO generation by (SePEI/Alg)25 coated on SS, Ti and NiTi from 50 μM 
GSNO, 50 μM GSH and 50 μM EDTA.  The metal pieces were immersed into/removed 
from the reaction cell as indicated by the (↑) and (↓) arrows. 
 
 The NO production from given amounts of GSNO and GSH was also plotted against 
the number of bilayers (see Figure 4.4).  Surprisingly, the NO fluxes only slightly varied 
in a narrow range between 5 - 6 x 10-10 mol cm-2 min-1, instead of scaling proportionally 
along the number of bilayers coated.  This observation was obviously contradictory to the 
results shown in Figure 4.1 and Figure 4.2, both of which showed an increase in RSe 
catalyst deposited on the metal surfaces with increased number of bilayers.  So far, the 
mechanism for such a saturated NO flux remains unclear.  We speculate that it might 
relate to the internal structure of the LbL which dominates the diffusion of the GSNO and 
GSH through the polyelectrolyte matrix.  As discussed in Chapters 2 and 3, the 
heterogeneous NO generation occurs not only on the surface of the LbL, but also within the 
multilayer structure which requires the reactant species to diffuse into the LbL.  If the LbL  

































Figure 4.4. NO production from 50 μM GSNO, 50 μM GSH and 50 μM EDTA by 
(SePEI/Alg)n containing various number of bilayers. 
 
possesses a highly open structure, GSNO and GSH can diffuse through the entire 
multilayer so that all the RSe sites within the LbL are able to contribute to the RSNO 
decomposition.  In contrast, a dense structure tends to result in a limited permeability.  In 
the case of metal substrates, the reactants appear to only penetrate a shallow layer within 
the coating, which excludes the catalytic sites buried in the deep interior from being 
involved in the reaction.  As a result, the NO generation is determined by the permeable 
thickness and the RSe sites within that region rather than the total catalytic sites. 
 Nevertheless, these LbLs coated on metal surfaces were evaluated for their NO 
generation efficiency under typical biological conditions.  With 1 μM GSNO and 20 μM 
GSH, the LbLs produced a NO flux of ca. 0.6 x 10-10 mol cm-2 min-1, which is relevant to 
the biological NO flux from the EC monolayer as estimated to be 0.5 - 4 x 10-10 mol cm-2 
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min-1 (see Figure 4.5).12 This highlights the potential of this NO generation LbL to be used 
to render stent surfaces enhanced biocompatibility. 
 The plasma proteins comprise the largest group of polyelectrolytes in the blood, which 
can strongly interact with the highly charged LbL surface through electrostatic attraction 
and deposit on the surface via the same mechanism as the LbL assembly.  Indeed, proteins 
themselves have been widely used as constituents to build LbL structures to achieve given 
biological activity on the modified surface.13,14 To investigate the potential impact of 
surface protein adsorption, the SePEI based LbLs were placed in PBS buffers containing 
lysozyme (pI = 11) or albumin (pI = 4.5), which were selected to represent proteins bearing 
overall positive and negative charges at biological pH, respectively.15 Compared with a 
control sample immersed in fresh PBS without any protein species, the LbLs in albumin 
and lysozyme preserved 97.4% and 98.5% of the NO generation capacity after 1 h 
exposure, respectively (see Figure 4.6).  Apparently, the positively charged lysozyme was 
more likely to adsorb on the LbL surface; however such a surface fouling and the 
consequent surface charge reversal did not lead to a significant alteration in the NO 
generation activity of the LbL. 
 The surface texture of (SePEI/Alg)n coated on metal substrates was also evaluated 
using electron microscopy.  As shown in Figure 4.7, the LbLs coated on SS, Ti, and NiTi 
displayed a relative smooth surface morphology.  The (SePEI/Alg)25 on SS was then cut 
to create a fresh edge so that the cross-section of the multilayer could be viewed.  Under 
the microscope, the LbL was discovered to be a dense homogeneous coating with an 
estimated thickness of 20 μm.  It is not surprising that the LbL did not possess a “layered” 
structure as its name implied.  Indeed, the polyelectrolyte LbL has been well-recognized 
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as a fuzzy  
 
Figure 4.5. NO generation from biological relevant concentrations of GSNO and GSH at 














































Time (hr) Time (hr)        SS                Ti                NiTi 
 114
in comparison with the multilayer in contact with only PBS buffer. 
 






Figure 4.7. SEM pictures of the LbLs fabricated on metal surfaces: (a) (SePEI/Alg)25 on 
SS; (b) cross-section of (SePEI/Alg)25 coated on SS; (c) (SePEI/Alg)50 on Ti; 
(SePEI/Alg)50 on NiTi.  
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assembly of interpenetrated polymer chains.16,17 It is also noteworthy that such a thickness 
was acquired from a coating which had been completely dried to meet the high vacuum 
conditions required by SEM.  Under real reaction conditions, i.e., in buffers or biological 
fluids, the polyelectrolyte film is prone to swell. Indeed, a completely reversible 
swelling/deswelling cycle was observed on a LbL containing poly(allylamine 
hydrochloride) and poly(styrene sulfonate).18 The average volume percentage of water in 
the swollen film could be as high as 50%, dependent on the type of constituent polyion 
species as well as the thickness of the LbL. 
 
4.4. Conclusion 
 In this chapter, the previously described NO generating LbL coating was translated 
onto metal substrates.  Stainless steel, nitinol and titanium were selected due to their 
dominating use in coronary stents.  A consecutive deposition of SePEI and Alg 
polyelectrolytes was realized on these metal surfaces by monitoring the substrate mass 
during the coating procedure.  Similar to the earlier work conducted using quartz 
substrates, the LbLs fabricated on metal substrates showed substantial structural stability 
and catalytic activity.  However, the LbL coated on metal surfaces displayed a “saturated” 
NO flux which did not change accordingly as more bilayers were further deposited.  We 
postulate that such a saturated NO production is very likely due to the limited permeability 
of the polyelectrolyte matrix when deposited on metal surfaces.  Unfortunately, the 
relation between the permeability versus the polyelectrolyte species used to fabricate the 
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multilayer, as well as the coating conditions has not yet been thoroughly studied.  This 
reality makes it less possible to intentionally tailor the coating parameters to promote the 
diffusion of reactants within the polymer matrix.  Nevertheless, it has been reported that 
the permeability can be enhanced via exposing the LbL to certain organic solvents for an 
extended period of time.19  Thus, it might be worthwhile to screen possible solvents for 
this purpose to “loosen up” the interpenetrated polymer chains without significantly 
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 LAYER-BY-LAYER ASSEMBLY WITH COMBINED NITRIC OXIDE 
GENERATION AND SURFACE IMMOBILIZED HEPARIN  
 
5.1. Introduction 
Years of study on the molecular basis of thrombotic response have revealed an 
extraordinarily complicated physiological system is involved, not merely the 
supersensitive platelets but also a series of coagulation proteins that undergo a 
self-amplified reaction cascade.  Depending on the triggering mechanism (i.e., by tissue 
factors or surface adsorbed plasma proteins), the clotting cascade propagates along 
different routes but eventually converges into a common pathway in which prothrombin 
and factor X are activated into thrombin and factor Xa (FXa), respectively (see Figure 1.2 
for details).  In the natural hemostasis system, this common pathway is modulated by 
anti-thrombin III (AT-III), which effectively deactivates thrombin and FXa by 
co-interacting with heparin. Such awareness leads to the application of heparin as an 
anti-coagulant to mitigate thrombosis incidence after cardiovascular interventions.       
The structure of heparin consists of a disaccharide repeat unit (see Figure 2.2c) 
composed of a trisulfated induronic acid and a glucosamine.  The large number of 
sulfate and carboxylate groups result in a highly negatively charged polysaccharide
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backbone, which is essential to the bioactivity of heparin.  Indeed, the anti-coagulant 
electrostatically interacts with a binding domain enriched with lysine and arginine 
residues on AT-III to induce an allosteric activation of the enzyme, and subsequently 
accelerates the inhibition of thrombin and FXa (see Figure 5.1).  Despite of the potent 
anti-coagulation efficacy, unfractionated heparin is marked by its poor bioavailability and 
adverse immune response, largely due to the non-specific interaction between the highly 
sulfated polysaccharide chain and the positively charged domains on the plasma 
proteins.1 Low molecular weight heparin obtained from controlled depolymerization 
and/or fraction of the unfractionated heparin has emerged as a clinical substitute to 
manage thromboembolic disorders due to its improved bioavailability and reduced side 
effects.2,3 However, systemic application of either unfractionated or low molecular weight 
heparin tends to elevate the bleeding complications.4,5 As a result, surface-immobilized 
heparin has recently been pursued to create hemocompatible materials via a localized 
anti-coagulation effect. 
 The most widely used method to immobilize heparin is via amide bond formation 
between heparin and an aminated surface.  In our group, unfractionated heparin has 
been attached on aminated PVC and PU, which were further applied as an outer layer of 
NO release coatings to achieve a dual anti-thrombotic activity.6,7 Less frequently, the 
heparin chain is cleaved by nitrous acid at the glucosamine residues to produce an 
aldehyde end group8, which can react with surface amines to form a Schiff base. More 
recently, heparin was electrostatically deposited into a surface thin film using the LbL 
method with other natural macromolecules such as chitosan,9,10 hyaluronic acid11 and 








Figure 5.1. Schematic representation of the interactions among heparin, AT-III, FXa and 
thrombin (denoted as FIIa here).  The Lys/Arg designation illustrates the heparin 
binding site of AT-III.  The Ser/Arg residues represent the reactive sites of AT-III to FXa 
and thrombin.  The effect of heparin on the reaction between AT-III and thrombin (right) 
involves formation of a ternary complex in which heparin interacts with both AT-III and 
thrombin electrostatically.  In contrast, the inhibition of FXa does not require a direction 







direct methods such as FXa6,7,14 and FIIa15 chromogenic assays, or  indirect methods 
such as aTPP,9 PT9 or platelet activity tests.12  
In this chapter, novel LbLs with combined NO generation and surface heparin 
activity are reported.  Previously, a (SePEI/Alg)n multilayer was prepared using an 
automatic coating apparatus and the resulting coatings proved capable of generating a 
physiological level of NO under typical biological conditions.  The aforementioned 
(SePEI/Alg)n LbL is capped with an Alg outlayer and thus has excess negative charges on 
its surface.  However, the LbL coating sequence can also be terminated after deposition 
of an ouyer layer of SePEI.  In this circumstance, the SePEI outermost layer endows the 
mutilayer with a vast number of surfaceamine sites suitable to attach other active species.  
Herein, heparin was immobilized on the aminated LbL through two distinct methods: 
electrostatic deposition and covalent attachment.  The anti-FXa activity of these heparin 
immobilized surfaces was assessed using a chromogenic assay.  Further, it will be 
demonstrated that these heparinized LbLs are still capable of generating substantial 




Heparin sodium salt (Hep), sodium alginate (Alg, Mw 12-80 kD), glutathione (GSH), 
1-(3-dimethylaminopropyl)-3-ethylcarbodiimide (EDC), 5,5’-dithiol-bis(2-nitrobenzoic 
acid) (DTNB), fluorescein-5-isothiocyanate (FITC), fluorescein-5-thiosemicarbazide 
(FTSC) and 2-(N-morpholino)ethanesulfonic acid (MES) were obtained from 
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Sigma-Aldrich (St. Louis, MO) and used as received.  Bovine albumin (BSA) fraction V 
solution was purchased from Invitrogen Corp. (Carlsbad, CA).  Human anti-thrombin III 
(AT-III) and bovine Factor Xa (FXa) were purchased from Haematologic Technologies 
Inc. (Essex Junction, VT).  Chromogenix S-2222 was purchased from DiaPharma Group, 
Inc. (West Chester, OH).  Organoselenium immobilized polyethyleneimine (SePEI), and 
S-nitrosoglutathione (GSNO) were synthesized as described previously.16  All solutions 
were prepared with 18 MΩ cm-1 deionized distilled water obtained from a Milli-Q system 
(Millipore Corp., Billerica, MA). 
5.2.2. Fabrication of NO generation LbL 
The catalytic LbL was fabricated using a StratoSequence 6 (Nanostrata Inc., 
Tallahassee, FL).  The substrates were mounted on the automatic coating apparatus and 
dipped alternately into SePEI and Alg solutions (1 mg mL-1 in PBS) for 10 min.  Each 
deposition step was followed by a sequential washing in three batches of PBS for 1 min 
each to remove loosely adsorbed polymer and to minimize cross contamination of the 
coating solutions.  The coating cycles were repeated until the desired number of bilayers 
was achieved.         
5.2.3. Heparin immobilization 
Heparin was immobilized on the LbL surface through two distinct mechanisms: 1) 
electrostatically interacting with positively charged SePEI; and 2) covalently bonding to 
the amine sites via amide formation.  The physical adsorption of heparin was achieved 
by conducting a similar LbL procedure whereby the LbL was immersed in 1 mg mL-1 
SePEI and heparin PBS solutions, repeatedly.  Alternatively, heparin was covalently 
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attached to the LbL surface through reacting the carboxylate functional groups on the 
polysaccharide with the amine sites on SePEI.  To do so, the automatic LbL deposition 
was stopped after deposition of an outmost layer of SePEI so that an amine-rich surface 
resulted (denoted as LbL-NH2); otherwise, the multilayer was defaulted to have an Alg 
top layer.  To facilitate the coupling reaction, 20 mg heparin was pre-activated with 8 
mg EDC in 4 mL MES buffer (pH = 6) for 1 h.  The Hep-EDC adducts were separated 
from the reaction by centrifuging the mixture through a membrane with a MWCO of 3K 
for 15 min.  Then, the concentrate was redissolved into 1 mg mL-1 PBS solution in 
which the LbL-NH2 substrate was subsequently immersed for a given amount of time.   
5.2.4. UV-Vis detection 
The immobilization of heparin on the LbL surface, as well as the stability of the 
resulting structure, was monitored using a UV-Vis spectrophotometer (Lambda 35, Perkin 
Elmer, MA).  The FITC labeled SePEI and heparin species, denoted as SePEI-F and 
Hep-F, were employed exclusively in this study.  SePEI was modified as previously 
described in Section 2.2.3., while heparin was labeled using an amine-derivatized 
fluorescein species, fluorescein-5-thiosemicarbazide (FTSC, ε=78,000 M-1cm-1).  
Specifically, 40 mg heparin and 3 mg EDC were dissolved in 4 mL PBS, in which 0.4 mL 
DMF containing 5 mg mL-1 FTSC was added.  The mixture was allowed to react for 1 h 
and then washed with PBS using a centrifugal unit with MWCO of 3K. The labeled 
heparin shows a λmax at 504 nm.        
5.2.5. NO detection 
 Nitric oxide generation by the catalytic LbLs from GSNO in presence of GSH was 
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quantitated as described in Chapter 2.  
5.2.6.  Anti-FXa activity of immobilized heparin 
The surface bioactivity of the heparinized LbL was determined using a chromogenic 
anti-FXa assay.  A PU catheter segment coated with the heparinzed LbL was immersed 
in a microcentrifuge tube containing a solution composed of 224 μL PBS, 80 μL AT-III 
(103 μg mL-1) and 80 μL BSA.  After incubation at 37 ˚C for 2 min, 16 μL FXa (1 μg 
mL-1) was added and the mixture was incubated for 1 min.  Then, 40 μL S-2222 (2.5 mg 
mL-1) was added into the reaction followed by incubation for another 10 min.  The 
reaction was terminated by acidifying the solution with 160 μL acetic acid.  Three 
aliquots of 100 μL reaction mixture were then transferred into a 96-well microtiter plate 
and the absorbance at 405 nm was measured by the microplate reader.              
5.2.7.  Diffusion of GSH through the NO generation LbL 
The typical experimental set-up for monitoring the diffusion of GSH through the LbL 
is illustrated in Figure 5.2.  A piece of dialysis membrane (MWCO 12 ~ 14 kD) coated 
with LbL on both sides was mounted between two diffusion cells: one was charged with 
0.5 mM GSH/PBS solution (G cell) and the other was filled with fresh PBS buffer (P 
cell).  Such a high concentration of GSH was used in order to accelerate the diffusion.  
Before the test, the (SePEI/Alg)n LbL was proved stable at this GSH concentration even 
after 12 h immersion (data not shown).  Since GSH is prone to oxidize into the 
corresponding disulfide, the PBS buffer used in this study was pre-deoxygenated with 
house N2 for 1 h.  The set-up was then seated at room temperature with vigorous stirring     
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Figure 5.2. Diffusion experiment set-up. Film mounted between the two diffusion 
chambers was a piece of dialysis membrane (DM) coated with the NO generation LbL on 







in both chambers for 12 h.  The solution in the P cell was sampled in the beginning and 
at the end of the diffusion period to determine the amounts of GSH that diffused through 
the membrane.  Three tests were performed in a row and the concentrations of GSH 
acquired were averaged.  After each test, the cells were filled with fresh PBS and seated 
for 12 h to thoroughly extract any residual GSH trapped in the membrane and the LbL 
structure as well. The same piece of membrane was allowed to adsorb another layer of 
SePEI and then reacted with EDC activated heparin for 12 h.  After the heparin 
immobilization, the membrane was soaked in PBS overnight to remove any unreacted 
and loosely bounded species.  Subsequently, another three diffusion tests were 
performed on this heparin modified membrane using the same experiment set-up.   
The thiol concentration in the P cell solution was quantitated using Ellman’s reaction.  
Specifically, 100 μL sample solution or calibration standard was injected into a microtiter 
plate well followed by addition of 100 μL 5 mM DTNB in 100 mM phosphate buffer (pH 
= 8.0).  The reaction was incubated at room temperature for 10 min and the UV-Vis 
absorbance at 414 nm was then measured using a microplate reader.  
 
5.3. Results and Discussion 
5.3.1.  Deposition of (SePEI/Hep)m on the surface of (SePEI/Alg)n NO 
generation LbL 
 The structure of heparin is characterized by the large number of negative charges 
distributed along the polysaccharide backbone.  This polyanionic structure, combined 
with the potent anticoagulant activity, makes heparin a frequent constituent in 
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hemocompatible LbL assemblies.11-14 However, our attempts to fabricate a multilayer 
using heparin and SePEI directly on quartz surface did not succeed (see Section 2.3.2).   
Interestingly, however, a stepwise growth of (SePEI-F/Hep)m was observed on a quartz 
surface pre-coated with a (SePEI/Alg)10 (see Figure 5.3a).  The absorbance at 510 nm 
was extracted from the spectra and plotted against the number of dipping cycles, which 
reveals a linear correlation (see Figure 5.3b).  In another experiment, the (SePEI/Hep)m 
LbL was also found to form on a surface pre-coated with (PDDA/Alg)2 (data not shown).  
These results imply that heparin is more likely to form stable LbL with SePEI on the 
surfaces where a substantial amount of polyelectrolytes are already adsorbed.  We 
speculate that this might be due to the relatively small molecular weight of heparin, as 
well as the slow early-stage growth of LbLs.  Indeed, as previously discussed in Section 
2.3.3, the LbL structure grows very slowly in the first couple of bilayers.  It was then 
discovered by SEM that the quartz substrate was not fully covered by the LbL, 
presumably due to the low surface charge density.  Rather, the polyelectrolytes first 
formed scattered particles which gradually merged into a continuous layer as the coating 
procedure continued, associated with amplification of the surface charge.  Intuitively, it 
is relatively difficult for polyions with shorter chains (e.g., heparin) to undergo such a 
merging process due to their less outspreading structure. 
 The successful immobilization of heparin was confirmed by constructing the LbL 
using fluorescein labeled heparin and subsequently detecting the heparin content in the 
multilayer with a UV-Vis spectrometer (see Figure 5.4). The UV-Vis result shows a 
continuous increase at 510 nm as more coating cycles were performed.  This 










































Figure 5.3. (a) UV-Vis absorbance of (SePEI-F/Hep)m deposited on a quartz cuvette 
pre-coated with (SePEI/Alg)10; (b) correlation of the absorbance at 510 nm with the 
number of (SePEI-F/Hep) bilayers (n).  Please note that the SePEI used in the 



















Figure 5.4. UV-Vis absorbance of (SePEI/Hep-F)m deposited on a quartz cuvette 









stability of (SePEI/Hep)m was assessed under exaggerated reaction conditions by 
monitoring the decay of UV-Vis absorption (see Figure 5.5).  After 48 h, the 
(SePEI/Hep)m multilayer proved to preserve 96.3% SePEI and 93.7% heparin in its 
structure.  Notably, the stability of the (SePEI/Hep)m is very similar to the results 
previously obtained on (SePEI/Alg)n, which retained 96.7% SePEI after exposure to the 
same conditions for 2 d.  This observation further indicates that the failure to build a 
(SePEI/Hep)m directly on the quartz surface is somehow related to the initiation of the 





































Figure 5.5. Stability studies of (a) (SePEI-F/Hep)5 and (b) (SePEI/Hep-F)5 coated on a 
(SePEI/Alg)10. The cuvette was filled with PBS containing 50 µM GSNO and 50 µM GSH. 
After every 24 h, old soaking solution was decanted and the cuvette was refilled with fresh 
PBS containing same given concentrations of GSNO and GSH. The absorbance at (a) 500 
nm and (b) 510 nm was monitored after every refill. 
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 The surface heparin activity of these (SePEI/Hep)m LbL was assessed using an 
anti-FXa assay.  The key reagent in the assay is a chromogenic substrate composed of a 
peptide sequence coupled with a chromophore, which gives a dramatic absorbance 
change when cleaved from the peptide by FXa.  This chromogenic reaction can be 
effectively suppressed by heparin which can potentiate the deactivation of FXa by AT-III.  
Therefore, the UV-Vis absorption of the assay is inversely correlated to the heparin 
activity in the sample.  Indeed, the calibration curve clearly demonstrates an inverse 
linear relationship between the heparin activity in standards and the absorbance at 405 
nm (see Figure 5.6).  In Figure 5.7, the anti-FXa activity of the (SePEI/Hep)2 and 
(SePEI/Hep)4 was determined to be 1.6±0.4 mU cm-2 and 1.1±0.1 mU cm-2 based on 
the calibration curve, respectively (see Figure 5.7).  Not surprisingly, (SePEI/Hep)4 
showed a similar surface activity compared with (SePEI/Hep)2, provided that only the 
heparin species in the top layer are able to interact with FXa and AT-III.  This heparin 
activity is relatively low compared to results reported elsewhere,6,7 which is very likely 
due to the consumption of the negative charges on the heparin chain by PEI in the LbL, 
which is critical for the binding between the polysaccharide and AT-III. 
 The catalytic activity of a (SePEI/Alg)100(SePEI/Hep)4 was evaluated and compared 
with a (SePEI/Alg)100 control which does not top-coated with (SePEI/Hep)4 (see Figure 
5.8).  Although the (SePEI/Alg)100(SePEI/Hep)4 has 4 more layers of SePEI, the 
catalytic LbL shows a NO generation similar to the control.  This is probably because 
the catalytic activity is predominantly contributed by the underlying (SePEI/Alg)100.  
Also, no significant baseline increase was observed upon removal of the sample from the 
testing solution, indicating an absence of serious RSe leaching.    
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Figure 5.6. Calibration curve showing the relationship between heparin activity and the 























Figure 5.7. Surface anti-FXa activity of (SePEI/Hep)2 (LbL2) and (SePEI/Hep)4 (LbL4) 




















Figure 5.8. Nitric oxide generation by (SePEI/Alg)100(SePEI/Hep)4 from 50 μM GSNO 
and 50 μM GSH, compared with that of (SePEI/Alg)100.  Both coatings were fabricated 
on PU catheters (0.2 cm OD, 0.5 cm). The coating was immersed/removed as indicated 
by (↓) and (↑) arrows. 





LbL-(SePEI/Hep)4                     LbL        
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5.3.2.  Covalent attachment of heparin on (SePEI/Alg)n LbL  
 Heparin can also be covalently attached to an aminated surface, i.e., a NO generation 
LbL with SePEI in the outermost layer (LbL-NH2), via amide bonds.  A 
(SePEI/Alg)100SePEI was thus allowed to react with a PBS solution containing 1 mg mL-1 
EDC activated heparin, which was also labeled with a fluorescein probe.  After 12 h, the 
coating was thoroughly washed and characterized using UV-Vis, which revealed a 
significant absorbance at 504 nm (see Figure 5.9).  Compared with the electrostatic 
adsorption method (Figure 5.4), this absorbance increase is much higher, indicating that 
the heparin immobilization might not be limited to the surface.  This can be due to the 
diffusion of some low molecular weight heparin fragments into the LbL structure.  Such 




















Figure 5.9. UV-Vis measurement of (SePEI/Alg)100SePEI after 12 h coupling with 
fluorescein labeled heparin.  
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PBS buffer and monitoring the absorbance change over time.  As shown in Figure 5.10, 
the LbL lost only 44.2 % of the total heparin content after 10 d soaking in PBS.  
Nevertheless, this observation suggests that the heparin within the LbL is not covalently 
bonded. 
 The structural stability of (SePEI/Alg)n LbL during the heparin immobilization was 
also investigated by measuring the UV-Vis absorbance of a (SePEI-F/Alg)100SePEI 
before and after coupling with heparin.  As shown in Figure 5.11, a slight absorbance 
decrease of ca. 12% was observed, indicating some of the FITC labeled SePEI was 
dissociated from the LbL.  This is probably caused by the reorganization/dissolution of 
the polyelectrolytes within the LbL.  Although the alternating deposition of polyanion 
and polycation is usually expected to be an irreversible process, partial dissolution of the 
LbL structure has been reported upon change in pH17 or ionic strength.18 Therefore, the 
heparin segments diffused into the multilayer, which are also charged species, may have 
an impact on the interaction between SePEI and Alg. 
 Figure 5.12 shows the anti-FXa activity of these covalently bound heparinized LbLs.  
Notably, the control sample, which is a (SePEI/Alg)100 immersed in 1 mg mL-1 heparin 
solution for 12 h, proved active in FXa inhibition, which is probably because of the slow 
release of the heparin trapped in the multilayer film.  As previously discussed, the 
heparin impregnated in the (SePEI/Alg)n LbL is slowly released upon prolonged exposure 
to PBS.  Although the release has been demonstrated to be a very slow process (i.e., 
only several percent per day), it may still result in a surface anti-FXa activity due to the 
highly efficient enzymatic reaction involved in the assay. The 




















Figure 5.10. UV-Vis absorbance of (SePEI/Alg)100(SePEI-Hep-F) after immersing in 
PBS buffer for given amounts of time.   
 















Figure 5.11. UV-Vis absorbance of (SePEI-F/Alg)100SePEI before and after coupling 
with heparin.  Please note that the outmost SePEI layer does not carry fluorescein labels.  






























Figure 5.12. Anti-FXa activities of the covalently heparinized LbLs.  “EDC8”, 
“EDC12” and “EDC20” are used to denote the LbL that has been reacted with EDC 
activated heparin for 8, 12 and 20 hours, respectively.  A (SePEI/Alg)100 solely 
immersed in a heparin solution without any coupling reagent for 12 h was used as the 







scale according to the length of the coupling reaction time between the LbL-NH2 and the 
EDC activated heparin.  When the reaction time is extended from 8 h to 12 h and then 
20 h, the resulting surface activity is increased from 4.1±0.3 mU cm-2 to 6.7 ±0.3 mU 
cm-2 and then to 7.2±0.2 mU cm-2, respectively.  In comparison with the control sample, 
this effectiveness in FXa inhibition indicates that the observed anti-FXa activity is at least 
partially due to by the surface immobilized heparin.  It should be noted that the 
LbL-NH2 surface adsorbs heparin through electrostatic interactions as well.  Therefore, 
the surface activity should be contributed by not only the covalently attached but also the 
electrostatically adsorbed heparin molecules.  In a long term activity study, surfaces 
with covalently immobilized heparin demonstrated significant anti-FXa activities even 






























Figure 5.13. Long term surface anti-FXa activity of NO generation LbL with covalently 
attached heparin.  EDC8, EDC12 and EDC 20 denote LbLs covalently reacting with 
EDC activated heparin for 8, 12, and 20 h.  
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 In NO generation studies, a remarkable activity decrease was observed with the LbL 
which had been covalently coupled with heparin (see Figure 5.14).  This activity 
reduction (ca. 50%) is much greater than the amount of SePEI previously discovered to 
dissociate from the LbL, implying that the NO generation efficiency was impeded by 
mechanisms other than the loss of catalytic sites in the multilayer.  Nevertheless, 
LbL-Hep was still able to produce a NO flux of 1.1 x 10-10 mol cm-2 min-1 under typical 
physiological conditions (see Figure 5.15).   
 As mentioned in previous chapters, the catalytic NO generation occurs not only on 
the LbL surface but also in the polyelectrolyte matrix, which requires the GSNO and 
GSH reactants to diffuse into the multilayer. If the permeability of the LbL is altered 
during the heparin immobilization, the efficiency of NO production can be impaired.  
Therefore, a diffusion experiment was performed in which GSH was allowed to diffuse 
from a chamber containing 0.5 mM GSH (denoted as G cell) into another chamber 
containing fresh PBS buffer (denoted as P cell), through a dialysis membrane with 
(SePEI/Alg)100 coated on both sides.  As shown in Figure 5.16, the concentration of free 
thiols in the P cell increased by 12.8±0.8 μM after 12 h diffusion, which confirms that 
the GSH reducing agent does penetrate the dialysis membrane, as well as the two 
(SePEI/Alg)100 LbLs.  However, the concentration increase of GSH in the P cell was 
increased by only 7.4±0.9 μM after immobilization of heparin.  This result clearly 
suggests a hindered diffusion of GSH through the heparin immobilized multilayer. Such 
reduced diffusion can be caused by the possible EDC mediated coupling between SePEI 
and Alg during the heparin immobilization, which forms amide crosslinks that lead to a 


















Figure 5.14. Nitric oxide generation from 50 μM GSNO and 50 μM GSH by 
(SePEI/Alg)100 (LbL), and (SePEI/Alg)100(SePEI-Hep) (LbL-Hep) which has been 
reacted with heparin for 12 h.  Both coatings are coated on quartz slides with a surface 






























Figure 5.15. Nitric oxide generation from 2.5 μM GSNO and 20 μM GSH at 37°C by an 
(SePEI/Alg)100(SePEI-Hep) coated on quartz slide.  
LbL                  LbL-Hep  
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Figure 5.16. Diffusion of GSH reducing agent through (SePEI/Alg)100 (LbL) and 
(SePEI/Alg)100(SePEI-Hep) (LbL-Hep).  The concentration of free thiol was sampled 
after 12 h diffusion. 
 
containing 1 mg mL-1 EDC did not exhibit any decrease in NO generation activity (see 
Figure 17), which rules out the crosslinked structure as a possible cause for the slow 
diffusion.  Instead, we speculate that the decreased NO generation is due to the heparin 
species trapped within the multilayer which occupy the pores and hamper the 
permeability of the polyelectrolyte matrix.  Differing from the electrostatically adsorbed 
heparin molecules, which usually lay on the surface in a flat conformation, the covalently 
attached heparin may have loops or tails sticking out from the surface.  These 
free-flowing segments may also act as a negatively charged “fence” to block the GSH 
from diffusing into the LbL. 
 
5.4. Conclusion 






Figure 5.17. Nitric oxide generation from 50 μM GSNO and 50 μM GSH by 
(SePEI/Alg)100 after 12 h immersion in 1 mg mL-1 EDC solution, in comparison with the 
control LbL which was immersed in sole PBS.  The slide was immersed/removed as 
indicated by (↓) and (↑) arrows. 
 
(SePEI/Alg)n LbL were investigated.  First, heparin was electrostatically deposited on 
the LbL by interacting with SePEI to form a (SePEI/Hep)m top-layer, which was shown to 
be stable under typical NO generation conditions, as well as in buffer for extended period 
of time.  Compared with its counterpart without heparin immobilized top-layer, the LbL 
with (SePEI/Hep)m did not show a significant difference in overall NO generation activity.  
However, such a surface with electrostatically adsorbed heparin displays a very limited 
anti-FXa activity, probably due to the consumption of heparin AT-III binding sites.  
Alternatively, heparin was also covalently attached to the amine sites on the LbLs with 
SePEI in the outermost layer.  In this case, a higher surface heparin activity was 
achieved.  In the meantime, such LbL-Hep structures show a reduced NO generation 
activity and impede GSH diffusion through the multilayer, as demonstrated via diffusion 
tests.  These results invoke a very interesting question: which immobilization method 














leads to a better anti-thrombotic effect?  The thromboresistency of EC layer lining the 
human vasculature is an overall effect of several anti-coagulant and anti-platelet species, 
with the contribution from each species poorly understood.  Even for surfaces that 
possess a single anti-thrombotic feature, the threshold dose to achieve the satisfactory 
prevention of thrombosis has been rarely reported.19  Furthermore, the performance of 
an anti-thrombotic coating is also related to the type of device, which makes the question 
more complicated.  The best solution hitherto to this dilemma lies in actually evaluating 
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 CONCLUSIONS AND FUTURE DIRECTIONS 
 
6.1. Conclusions 
 The research in this dissertation has introduced a novel strategy to immobilize 
organoselenium (RSe) catalysts on diverse biomedical relevant substrates in order to 
achieve surface nitric oxide (NO) generation from endogenous S-nitrosothiols (RSNO).  
The RSe catalyst was first attached to a cationic polymer, polyethyleneimine (PEI), 
which was then fabricated into a stable structure via electrostatic interactions with a 
polyanion, sodium alginate (Alg), using a so-called Layer-by-Layer (LbL) technique.  
The pure physical driving force of the method is believed to be “universal” across diverse 
biomedical materials, regardless of their surface functionality and morphology.  
Provided that the promising in vivo anti-thrombotic potency have been observed with the 
NO release1-3 and Cu-based NO generation materials,4,5 such RSe immobilized LbLs 
have a potential application on various blood-contact biomedical devices to improve their 
hemocompatibility and reduce incidence of thrombosis.  
 The concept of such a NO generation LbL was first realized on a quartz surface for 
characterization convenience (see Chapter 2).  Upon manually immersing the substrate 
into solutions containing organoselenium immobilized PEI (SePEI) and Alg, a successive 
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deposition of the polyionic species was observed via UV-Vis, contact angles and SEM. 
The Se content within the polyelectrolyte deposit was confirmed by XPS.  A very slow 
leaching of the RSe species (ca. 3% within 3 d) was discovered by extracting the LbL 
under exaggerated reaction conditions and determining the Se concentration in the extract 
with ICP-MS.  Nevertheless, the extracts were tested for possible systemic toxicity and 
irritation response.  No obvious symptoms were observed, indicating that such an RSe 
immobilized LbL is suitable for potential biomedical applications.  The NO generation 
capability of the (SePEI/Alg)n LbL was thoroughly investigated via chemiluminescence, 
revealing an enduring catalytic activity and a well-defined correlation between the 
activity and the number of bilayers deposited in the LbL.  Then, the NO generation LbL 
was successfully translated to biomedical relevant surfaces such as polyurethane and 
silicone rubber to prove its anticipated “universal” applicability.  All the aforementioned 
experiments strongly suggest that the LbL deposition is an effective approach to 
immobilize the RSe species to achieve a confined surface NO generation.   
  The focus was then shifted to whether these RSe immobilized LbLs contain enough 
bilayers to generate NO at a rate comparable to that of human endothelium, particularly 
under typical biological conditions in which only low micromolar RSNOs are present 
(see Chapter 3).  For this purpose, one hundred bilayers were deposited on quartz 
substrates using an automatic coating apparatus.  The automatically prepared LbL 
proved capable of generating a NO flux of 1.5 x 10-10 mol cm-2 min-1 from typical 
concentrations of GSNO and GSH.  This NO flux is of the same order of magnitude 
with the natural NO flux from the endothelium monolayer (0.5 - 4 x 10-10 mol cm-2 
min-1).6 For the first time, the coating was applied on a polyurethane catheter and 
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implanted in rabbits.  No significant activity loss was detected after 4 h of implantation.  
This observation, in combination with the biologically relevant amount of NO generated 
by this RSe immobilized LbL, suggests that this endothelium-mimicking coating may be 
useful for cardiovascular devices.  
 Encouraged by the results in Chapters 2 and 3, the LbL was applied on metal 
substrates which constitute an important class of materials in cardiovascular devices (see 
Chapter 4).   On all three exemplary metals (stainless steel, titanium, and nitinol), the 
LbL showed significant NO generation capability.  Even though the metallic alloys have 
various elemental compositions; there were no significant deviations in terms of the 
quantity or the activity of the LbL deposited on their surfaces.  Notably, a saturated NO 
flux was observed which did not scale as more bilayers were added to the LbL, 
presumably due to the diffusion barrier caused by the highly entangled polyelectrolyte 
network.  Nevertheless, this saturated NO flux is still within the range of the basal NO 
fluxes from the endothelium monolayer.     
 In all the abovementioned experiments, the LbLs were fabricated with anionic Alg in 
the outmost layer.  This is because negatively charged surfaces are known to be more 
hemocompatible by reducing surface protein adsorption.  However, the LbL can also be 
designed to have a SePEI outmost layer.  The resulting amine enriched surface is very 
attractive to immobilize other anti-thrombotic species, such as heparin, for a synergistic 
multifaceted effect.  Two distinct strategies were investigated to immobilize the heparin 
polysaccharide: 1) electrostatic adsorption, and 2) covalent attachment via amide 
formation.  By monitoring the UV-Vis absorbance from the fluorescently labeled 
heparin molecules, both methods proved to be effective to immobilize heparin on the 
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aminated LbL surface.  Using a chromogenic assay, it was shown that the surface with 
covalently attached heparin is more active in terms of inhibition of factor Xa.  However, 
such covalently attached heparin tends to lower the NO generation efficiency of the 
underlying RSe immobilized multilayer by impeding the diffusion of reactant RSNO and 
RSH species through the polyelectrolyte matrix.   
 
6.2. Future Directions 
6.2.1. In vivo anti-thrombotic evaluation of RSe immobilized LbL 
 Despite the promising data obtained in vitro, the ultimate evidence of an 
anti-thrombotic effect lies in examining the coating in vivo.  In the preliminary tests, the 
LbL was applied to commercial polyurethane catheters which were later implanted in the 
veins of rabbits (see Chapter 3). After 4 h implantation, the catheters were explanted and 
tested for surface NO generation activity, which revealed no significant activity loss.  
This result highlights that the catalyst immobilized in such a polyelectrolyte multilayer 
can resist the sheer stress of the flowing blood, as well as the large number of reactive 
species in plasma.  However, the LbL is prone to delamination upon insertion of the 
catheter into the blood vessel, which indicates a poor adhesion of the multilayer on the 
substrate.  In Chapter 2, the LbL has proved applicable on neutral polyurethane surfaces.  
The growth of the multilayer is believed to be initiated by the non-specific adsorption of 
branched SePEI onto the polymeric substrates.  However, such a non-specific 
interaction is much weaker than the cooperative electrostatic attractions between two 
oppositely charged polyelectrolytes, not to mention that the polyions in the highly 
penetrated structure further stabilize the LbL through chain entanglement.  Therefore, 
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the adhesion of the LbL to the substrate remains the weakest link, although a strong 
cohesion within the multilayer has been implied by the difficulties encountered in 
digesting the LbL film.  To ensure a successful implantation, catheters with a diameter 
much smaller than the target blood vessel should be selected in order to mitigate the 
friction and the shear force upon insertion.  Also, an adhesion promoting layer might 
also be necessary to prevent delamination.  For example, the catheters can be top-coated 
with a thin layer of aminated polyurethane to introduce ionizable free amines, which may 
enhance the interaction between the polyurethane surface and the first several bilayers.  
6.2.2. Aromatic organoselenium species as catalysts for NO generation from 
RSNO 
 So far, the RSe species employed in our NO generation chemistry are alkyl 
diselenides such as 3,3’-diselenidedipropionic acid (SeDPA) and selenocystamine 
(SeCA).  It should be noted that there are other RSe candidates worth exploring in 
pursuit of a better catalyst.  Ebselen (2-phenyl-1,2-benzoisoselenazol-3-(2H)-one) is a 
promising target in particular due to its proven glutathione peroxidase mimicking 
activity.7  In the proposed mechanism (see Scheme 6.1), Ebselen reacts with a thiol to 
afford a selenenylsulfide intermediate, which further disproportionates slowly to the 
corresponding diselenide with the elimination of disulfide.8  Given the reported 
decomposition of RSNOs by the alkyl diselenide species, it is very likely that the Ebselen 
may display the same catalytic activity.  Notably, the compound possesses a Se-C 
(aromatic) bond that avoids selenium release and maintains the low toxicity of Ebselen.  
This feature potentially endows the catalyst with long-term activity and reduces the 
toxicity concern.  Indeed, the Ebselen already underwent Phase III clinical trials in 
Japan as an antioxidant. 
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Scheme 6.1. Proposed mechanism of Ebselen catalyzed reduction of peroxide by 
glutathione. (RSH, glutathione; RSSR, disulfide; R’OOH, peroxide; ROH, alcohol.)  
 
 
 Scheme 6.2 represents a general synthesis pathway of Ebselen derivatives via a 
diselenosalicylic acid precursor (1), which is then converted into a highly reactive 
2-(chloroseleno)benzoyl chloride (2).  Compound 2 can react with derivatized aniline on 
which the R1, R2, and R3 groups can be systemically tailored to produce the 
corresponding Ebselen compounds.  If the aniline derivative used in the synthesis 
contains a reactive functionality, such as a carboxylate, amine or hydroxyl group, the 
resulting Ebselen product can be immobilized into underlying polymer matrices via 
covalent attachment and herein be utilized as an NO generation material.  It is possible 
that changing the substituent groups R1-3 may impact the catalytic activity of the Ebselen 
species.  Therefore, it will be very interesting to examine the activity of different 
Ebselen derivatives to elucidate the structure-activity correlation with respect to NO 
 153




Scheme 6.2. Synthesis pathway of Ebselen through a diselenodisalicylic acid precursor.9   
 
6.2.3. NO generation fluorinated surface modifier for polyurethane 
 All biomedical polymer applications have requirements that can be divided into bulk 
property and surface property categories.  On one hand, the polymer must possess 
appropriate mechanical features, i.e., robustness, flexibility and processability etc., to 
perform anticipated functions.  On the other hand, the material surface directly 
contacting the biological environment (i.e., with tissue or blood) has to be 
“biocompatible” without provoking severe adverse responses.  However, the chances 
are remote that both surface and bulk properties can be optimized in a single polymer.  
This basic dilemma of biomaterials development has often resulted in a post-fabrication 
surface treatment or a top-coating, the processing of which must be adapted to the 
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specific physical form of the device or component.     
 A strategy to circumvent this post-fabrication surface modification is to blend the 
base polymer with a small amount of surface modifiers which spontaneously migrate to 
the surface in high concentration.  This approach takes advantage of the propensity of 
condensed phase material to minimize their interfacial energy.  An exemplary surface 
modifier is a polyethylene oxide (PEO) containing block copolymer, which has been 
reported capable of migrating to the surface after being blended in a polyurethane base 
polymer.  This enhances surface hydrophilicity and diminishes protein adsorption.10,11 
Recently, tri-block surface modifiers comprising a polyurethane oligomer, a fluoroalkyl 
end-cap and a bioactive pendant (e.g., a peptide sequence) have also been used to bring 
the bioactive component to the surface of the polyurethane base polymer.12-14  It has 
been found that as little as 0.5 % modifier is enough to saturate the polyurethane 
surface.13  More importantly, the bioactive species still exhibit their bio-functionality 
after migration to the surface.  For example, an RGD sequence attached to a fluorinated 
modifier has been shown to promote the adhesion of human monocytes on polyurethane 
in which the modifier was blended.13 The major advantage of using these surface 
modifiers is that the surface properties can be tailored via a simple blending step before 
fabrication of the surface without significantly changing the properties of the bulk 
polymer.  
 Similarly, the aforementioned chemistry can be used to create a NO generating 
surface on polyurethane by grafting an RSe catalyst on a fluorinated additive and then 
blending into the base polymer. By doing so, the catalyst can migrate along the 
fluoroalkyl chains onto the surface to form a NO generation layer spontaneously after the 
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blend is molded into the desired shape.  The modifier can be prepared via a synthetic 
route shown in Scheme 6.3.14,15 First, an excess amount of lysine diisocyanate is reacted 
with a diol to yield a polyurethane prepolymer with isocyanate groups on both ends.  
The fluorinated component can be introduced by capping the prepolymer with a small 
molecule fluoroalcohol.  Then, the ester pendant can be hydrolyzed under acidic 
conditions into carboxylic acid, which reacts with many aminated RSe catalysts via 
amide bond formation.  Alternatively, the carboxylic acid can be converted into an acid 
chloride, which can react with RSe possessing weaker nucleophiles, such as alcohols.    
 Obviously, application of these fluorinated PU additives is not limited to the NO 
generation chemistry discussed above.  For example, the additive can also be derivatized 
with S-nitrosothiol species, targeting a new class of NO release materials.  Other species 
capable of enhancing blood compatibility, such as heparin, phospholipids, and 
plasminogen etc., can also be attached to the fluorinated head group and subsequently 
blended into the bulk polymer, whereby the polyurethane surface can be modified via the 













Scheme 6.3. Synthesis of RSe immobilized fluorinated surface modifier. (LDI, lysine 
diisocyanate; PTMO, polytetramethyl oxide; PU, polyurethane; FA, fluoroalcohol; FSM, 
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